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Chlamydien sind gram-negative humanpathogene Bakterien, die eine Vielfalt an 
Krankheiten im Menschen verursachen. Dazu gehören die durch Infektion verursachte 
Blindheit wie auch zahlreiche sexuell übertragbare Krankheiten. Chlamydien sind obligat 
intrazelluläre Bakterien; sie entwickeln sich innerhalb einer membranumhüllten Vakuole 
innerhalb der Zelle, der sogenannten Inklusion. Ihnen ist ein einzigartiger biphasischer 
Entwicklungszyklus zueigen, während dessen sie teilweise von der Wirtszelle abhängig 
sind. 
Das Immunsystem des Wirts hat die Fähigkeit, Zellen, die Bakterien tragen, zu erkennen 
und zu eliminieren. Infizierte Zellen exprimieren vermehrt MHC Klasse I oder II Moleküle 
auf der Oberfläche, die durch CD+ T Zellen erkannt werden. Daraufhin wird die Zelle 
durch Apoptose zerstört. Apoptose ist eine Form des programmierten Zelltods, die eine 
Kaskade von biochemischen Ereignissen beinhaltet, die zu einer systematischen Auflösung 
des Zellapparates und dessen Entfernung aus dem Organismus führt, ohne eine 
Entzündung auszulösen. Chlamydien haben verschiedene Strategien entwickelt, um vom 
Immunsystem unerkannt zu bleiben oder die Wirtszelle vor der Zerstörung zu bewahren. 
Diese hervorragende Eigenschaft der Chlamydien, Wirtszellen effektiv vor der Apoptose 
zu schützen, hilft ihnen, lange genug im Wirt zu überleben und zu replizieren, um ihren 
Entwicklungszyklus erfolgreich zu beenden. 
Gegenstand der vorliegenden Arbeit war es,  die Mechanismen aufzuklären, durch die 
Chlamydien die Wirtszellapoptose regulieren. Dabei wurde Chlamydia trachomatis als ein 
Modellorganismus gewählt. 
Es konnte beobachtet warden, dass Chlamydien durch die Modulation spezifischer 
Wirtszellproteine verschiedene Wege der Apoptose verhindern können. Mcl-1 und cIAP-2 
erwiesen sich als bedeutende Faktoren, die durch die Infektion hochreguliert und absolut 
notwendig für die Inhibierung der Apoptose durch Chlamydien waren. Hochregulation der 
Mcl-1 Expression führte zu einem Block im apoptotischen Weg oberhalb der 
Mitochondrien. cIAP-2 zusammen mit anderen Inhibitor of Apoptosis Proteins (IAP) 
verhinderten die Aktivierung von Caspase-3, denfinalen Schritt in der apoptotischen 
Kaskade. Weiterhin wurde beobachtet, dass die Aktivierung des MAPKinase-Signalweges 





Eine interessante Beobachtung war, dass cIAP-1, cIAP-2 und XIAP miteinander 
interagieren und in hochmolekularen heteromerischen Komplexen in der Zelle existieren. 
Abwesenheit von XIAP verhinderte die Bildung dieses Komplexes. Es wurde auch 
beobachtet, dass der IAP Antagonist Smac wie auch Caspase-3 während der Apoptose zum 
IAP-Komplex rekrutiert werden. Daraus konnte gefolgert werden, dass der IAP-Komplex 
eine funktionale Rolle bei der Regulierung der Caspase-Aktivierung spielt. 
Ein Hochdurchsatz-Screen wurde durchgeführt, um andere Wirtszellfaktoren, die für die 
Apoptoseinhibierung durch die Chlamydien verantwortlich sind, zu identifizieren. Neben 
Mcl-1 waren die identifizierten Faktoren hauptsächlich Mitglieder des MAP Kinase-
Signalweges. Dabei wurde deren Rolle für die Apoptoseresistenz bestätigt. Eine 
weiterführende Analyse der im Screen ermittelten Faktoren identifizierte eine Funktion 
von HIF-1 alpha bei der Modulation der Expression anti-apoptotischer Faktoren während 
der Infektion. Es wurde beobachtet, dass HIF-1alpha stabilisiert und zum Nukleus 
transloziert wird. Es ist bekannt, dass HIF-1alpha HIF-1betaim Nukleus binden kann, um 
den funktionalen Transkriptionsfaktor HIF zu bilden. Dieser reguliert die Expression 
verschiedener Überlebensfaktoren, unter anderem Mcl-1. HIF-1 alpha Knockdown 
inhibierte die Chlamydien-induzierte Hochregulation von Mcl-1 mRNA-Expression. 
Die vorliegende Arbeit zeigt, dass die Chlamydien-Infektion die Apoptose an 
verschiedenen Stellen inhibiert. Die Infektion führt zur Hochregulation von anti-
apoptotischen Faktoren, inklusive Mcl-1 und cIAP-2, in Abhängigkeit von der Aktivierung 
von MAPKinasen. HIF-1alpha wird durch die Infektion stabilisiert, wahrscheinlich durch 
infektionsbedingte Hypoxie, und bewirkt dietranskriptionelle Hochregulation von Mcl-1 
und cIAP-2. 
Daraus kann geschlussfolgert werden, dass die chlamydiale Infektion ein interessantes 
Szenario darstellt, bei dem die Bakterien die Zelle invasieren und diese vor dem Zelltod 
schützen, indem sie Wirtszellüberlebenssignalwege aktivieren. Es gibt wachsende Evidenz 
dafür, dass Chlamydien-Infektionen mit verschiedenen Krebsarten im Zusammenhang 
stehen. Das Verständnis der Modulation von SignalwegenderWirtszelledurch Chlamydien 
kann bei der Aufklärung der Rolle chlamydialer Infektionen in der Tumorentstehung und –





Chlamydia are gram-negative pathogens causing widespread diseases in humans including 
infectious blindness as well as sexually transmitted diseases. These are obligatory 
intracellular and live inside a membrane bound vacuole, termed inclusion, in the cell. 
Chlamydia are dependent on the host cell to meet their nutritional demands during their 
biphasic life cycle.  
The host cell immune system has the ability to recognize and eliminate cells that are 
carrying most bacterial infections. CD+ T cells can identify infected cells by the surface 
expression of MHC Class I or II molecules and subsequently destroy the cell by the 
process of apoptosis. Apoptosis is a form of programmed cell death involving a chain of 
biochemical events which lead to systematic dismantling of the cellular apparatus and its 
removal in an ordered way. However, Chlamydia have evolved various strategies whereby 
they not only prevent the detection of the host cell by the immune system, but also protect 
it from destruction by the immune system in case of recognition. This remarkable ability of 
Chlamydia to robustly protect host cells from apoptosis helps it to survive long enough in 
the host cell to complete the life cycle.  
The present study was aimed at determining the mechanisms by which Chlamydia interfere 
with the apoptosis induction in host cells, using Chlamydia trachomatis as a model 
organism. 
It was seen that chlamydial infection blocked the apoptotic pathway at multiple levels by 
modulation of specific host cell proteins. Mcl-1 and cIAP-2 were two most prominent 
factors that were up-regulated during the infection, and absolutely required for apoptosis 
inhibition. Increased expression of Mcl-1 led to a block in the apoptotic pathway upstream 
of the mitochondria. cIAP-2, together with other inhibitor of apoptosis proteins (IAPs), 
blocked the activation of caspase-3 at the final step of the apoptosis cascade. Further, it 
was observed that the activation of the MAPK pathways during infection was needed for 
the up-regulation of Mcl-1 and cIAP-2.  
An interesting observation was that cIAP-1, cIAP-2 and XIAP interact with each other and 
exist in a high molecular weight heteromeric complex in cells. Absence of XIAP was seen 





get recruited to the IAP complex during apoptosis induction, suggesting that the IAP 
complex has a functional role in regulating caspase activation during apoptosis. 
A high throughput RNAi screen was performed to identify other host factors required for 
the apoptosis resistance during the infection. Besides Mcl-1, the targets from the screen 
prominently included members of the MAPK pathways, confirming their role in the 
apoptosis resistance. Pathway analysis of the targets identified the role of HIF-1 alpha in 
modulating the expression of the anti-apoptotic factors during infection. It was observed 
that during infection, HIF-1 alpha gets stabilized and translocates to the nucleus. It is 
known that HIF-1 alpha can bind to HIF-1betain the nucleus to form the functional 
transcription factor HIF, which can regulate the expression of survival factors like Mcl-1. 
This was seen to be the case, because knock down of HIF-1 alpha abrogated the infection 
induced up-regulation of Mcl-1 at the mRNA levels.  
From the present work it can be concluded that chlamydial infection blocks the apoptotic 
pathway at various levels. The infection leads to the up-regulation of prominent anti-
apoptotic factors including Mcl-1 and cIAP-2 in a MAPK dependent fashion. HIF-1 alpha 
gets stabilized in the infected cells, probably due to infection induced hypoxic conditions 
and subsequently results in the transcriptional up-regulation of Mcl-1 and cIAP-2.  
Thus the chlamydial infection presents an intriguing scenario where bacteria invade a cell 
and then protect it by activating the host survival pathways. Moreover, there is growing 
evidence relating chlamydial infection with certain cancers. The understanding of the 
chlamydial modulation of cell signalling will be helpful in unravelling the mechanisms of 
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Interactions between bacteria and host cells are of diverse kinds. In an early stage of life on 
earth, a bacterial invasion into an archaeon cell led to an endosymbiotic relationship 
between the two [1]. The parasitic bacteria contributed to the metabolism of the host cell 
through respiration while taking up nutrition from the cell. Eventually this endosymbiosis 
resulted in the evolution of an organelle in the cell - the mitochondria, which became 
responsible for the respiration in the cell. However, it appears that along with the function 
of respiration, another role has been passed over to the present day eukaryotic cell as a 
legacy from the initial incorporation of the aerobic bacteria into the ancestral eukaryote – 
that of apoptosis [2]. The present day eukaryotic apoptotic machinery seems to be formed 
of several apoptotic factors originating as a consequence of the mitochondrial 
endosymbiosis and newly emerging eukaryotic domains that act as adaptor molecules [3]. 
Mitochondria play a central role in the life and death decisions of a cell. It is well accepted 
that once the mitochondrial outer membrane gets permeabilized, the apoptotic factors 
released into the cytosol irreversibly commit the cell to apoptosis.  
A billion years hence, in a contrasting mode of interaction between another bacterium, 
Chlamydia, and eukaryotic cells, the bacterium blocks the apoptotic machinery of the host 
cell. In a reversal of roles, here is a pathogen that strongly protects host cells against 
destruction by their own organism [4].  
1.1 Chlamydia 
Chlamydia refers to a genus of obligate intracellular bacteria having a unique biphasic life 
cycle. Initially classified as viruses, these were later shown to be gram-negative bacteria on 
the basis of their cell wall architecture and composition apart from their growth by binary 
division [5]. Many chlamydial species are pathogenic, responsible for a diseases such as 
blinding trachoma and respiratory tract diseases in humans.  
1.1.1 Chlamydial taxonomy 
Based on the taxonomic analysis of the 16S and 23S rRNA genes the order Chlamydiales 
is categorized into distinct groups at the family level including Chlamydiaceae, 
Parachlamydiaceae and Simkaniaceae [6]. The family Chlamydiaceae consists of two 





trachomatis, Chlamydia muridarum and Chlamydia suis, while Chlamydophila contain 
Chlamydophila pecorum, Chlamydophila pneumoniae, Chlamydophila psittaci, 
Chlamydophila abortus, Chlamydophila caviae and Chlamydophila felis. 
The genomes of several of the chlamydial species have been determined. For example, 
Chlamydia trachomatis serovar D genome contains 1,042,519 nucleotides and an estimated 
894 protein-coding genes. It is also reported to contain an extrachromosomal plasmid of 
7493 nucleotides [7]. 
1.1.2 Chlamydial diseases, medical significance 
Chlamydia have been implicated in various diseases affecting not only human beings but 
also several animals.   
Chlamydia trachomatis is responsible for the most common sexually transmitted diseases, 
as well as potentially blinding trachoma, throughout the world. C. trachomatis can be 
classified into at least 15 serologically distinguished serovars (serovariants) based on 
immunogenic epitope analysis of the major outer membrane protein (MOMP) with 
polyclonal and monoclonal antibodies. These serovars can be divided into two biovars 
(biovariants): trachoma and Lymphogranuloma venereum (LGV). The trachoma serovars 
(A-C) invade mucosal epithelia in the ocular tissue which can lead to endemic blinding 
trachoma. The serovars D-K infect the urogenital tract causing sexually transmitted 
diseases. The LGV serovars L1, L2 and L3 invade lymph nodes causing the sexually 
transmitted systemic syndrome LGV (lymphogranuloma venereum) [8,9,10].  
Chlamydophila pneumoniae causes human respiratory tract diseases, with implications in 
around 6-25 % of community acquired pneumonia. Besides pneumonia, C. pneumoniae is 
also responsible for infections including pharyngitis, sinusitis, otitis, acute bronchitis, 
persistent cough, chronic obstructive pulmonary disease and Flu – like syndrome 
(Grayston et al., 1986; Grayston, 1992). Less common infections include extra-respiratory 
acute infections which might lead to cardiovascular diseases like acute myocarditis, 
pericarditis and endocarditis or neurological disorders like encephalitis, meningitis, 
Alzheimer’s disease or Guillain-Barre syndrome [11,12]. In addition, seroepidemiology 
studies have shown an association with coronary artery disease [13,14].  
Chlamydophila psittaci and Chlamydophila pecorum were implied in several animal 
diseases. C. psittaci infections are widespread in nature, with almost all avian species and 





of diseases including enteritis, urogenital infections and pneumonia. C. psittaci can also 
lead to psittacosis in humans [15]. C.  pecorum infects ruminants and swine causing 
diseases such as polyarthritis (“stiff-lamb” disease), conjunctivitis, pneumonia, metritis, 
encephalomyelitis and inapparent enteric infections [16].  
Recently, novel species of Chlamydia have been discovered including Parachlamydia 
acanthamoebae and Simkania negevensis, and implicated as human respiratory pathogens. 
Studies have also shown that free-living amoeba could support chlamydial multiplication 
and thus act as  reservoir or vector of chlamydial infections [17].  
1.1.3 Life cycle of Chlamydia 
Chlamydiae have a unique biphasic life cycle, consisting of the infectious Elementary 
Bodies (EBs) and the metabolically active Reticulate Bodies (RBs). Before infecting a cell, 
Chlamydia exists in the form of the metabolically inactive EBs that are able to survive in 
the extra-cellular environment. The EBs are approximately 0.2-0.3 μM in diameter and 
display a condensed nucleoid. After infecting a cell, the EBs differentiate into the RBs, 
which are around 1 μM in diameter and display a dispersed chromatin structure and are 
metabolically active. The RBs are metabolically active inside the cell, where they grow in 
size and multiply by binary fission. Subsequently, the RBs differentiate to form EBs, 
which are then released from the cell to infect new cells, and continue the life cycle 
[18,19].  
Within 8-12 h after entry, the EB within the vacuole differentiates into the intracellular, 
metabolically active, replicating RB that measures about 1 μM (Moulder, 1985; 1991). 
Differentiation of a RB from the EB involves an increase in the size, reduction of the 
disulfide links in the outer membrane, unraveling of DNA in the condensed nucleoid and 
the appearance of granular ribosomes [20]. The initiation signal for the differentiation of 
EB into RB is not known. EBs exposed to reducing environment commence biochemical 
events such as glutamate oxidation that are thought to possibly be critical for 
differentiation [21]. However, low pH does not trigger the transition process. The RB 
multiplies by binary fission in the inclusion, the membrane-bound vacuole, producing 
daughter cells that are approximately similar in size [19]. By 18 h post infection, a 
proportion of the developed RBs begins to transform back to EBs, while the remainder 
continues to divide in the growing inclusion [22]. The environmental signals that induce 





EBs in the inclusion that may contain up to a thousand progeny. The organisms acquire 
ATP, synthetic intermediates and essential metabolites needed for survival from the host 
cell through the inclusion membrane. At the end of a productive cycle of development, the 
cell ruptures and the released bacteria infect neighboring cells, repeating the events of the 
cycle [19]. Although Chlamydiae undergo similar developmental cycle, they differ in the 
time needed to end one cycle.  
1.2 Apoptosis 
Cell death is a fundamental aspect of multicellular life forms, with crucial roles during 
development, and tissue homeostasis. To this end, cell death occurs in a regulated manner, 
consisting of a well defined sequence of events. Programmed Cell Death, PCD, was first 
defined as the active physiological process of cell death that is dependent on signalling 
events in the dying cell [23]. Different types of PCDs were later characterized, including 
apoptosis (Type I PCD) and autophagy (Type II PCD) [24].  
Apoptosis is a form of programmed cell death involving a chain of biochemical events 
characterized by distinct morphological changes in the cell including cell shrinkage, 
pyknosis, plasma membrane blebbing, and finally karyorrhexis and formation of apoptotic 
bodies [25]. Morphologically, a cell dying by apoptosis becomes rounded and retracts from 
the neighbouring cells. Thereafter, there is a period of dynamic plasma membrane 
blebbing, resulting in the detachment (pinching off) of the blebs in the form of apoptotic 
bodies. The apoptotic bodies consist of cytoplasma and tightly packed organelles enclosed 
within an intact plasma membrane, and are cleared from the system through phagocytosis 
by macrophages, parenchymal cells or neoplastic cells. Markers like the Phosphotidyl 
Serine (PS) are exposed on the surface of the apoptotic bodies to be recognised and 
phagocytosed. During this whole process, there is no release of cellular contents into the 
surrounding tissue. Moreover, the phagocytes release anti-inflammatory factors upon 
interaction with the apoptotic cells, resulting in effectively no inflammatory reaction [26]. 
In contrast to apoptosis, uncontrolled cell ceath (called necrosis) entails a rapid loss of 
membrane integrity and release of cellular components into the extracellular space, which 






Dysregulation of apoptosis leads to a variety of human pathologies including cancer, 
autoimmune diseases and neurodegenerative disorders [28,29,30,31].  
Defining features of apoptosis include the condensation and fragmentation of the nucleus, 
an event that is unique to apoptosis. There is also hydrolysis of the DNA into fragments of 
sizes that are multiples of 200 bp - a characteristic feature that is used frequently to 
recognize apoptosis [32]. In addition there is also fragmentation of the golgi apparatus, the 
endoplasmic reticulum and the mitochondrial networks. The mitochondrial fragmentation 
has a crucial role in the apoptotic process as discussed below.  
During the process of apoptosis, more than 400 proteins undergo restrictive hydrolysis. 
Although a majority of these proteins cleaved could play some role in the apoptotic events, 
many cleaved proteins have no known functional relevance and appear to be innocent 
bystanders during apoptosis [33]. The main proteases involved in this extensive hydrolysis 
are members of the caspase family [34]. Besides caspases, some other proteases have been 
characterized in the apoptotic process. These include the lysosomal cathepsins, calpains 
and the granzymes [35].  
1.2.1 Caspases 
The primary proteases involved in apoptosis are the caspases or Cysteine Dependent 
Aspartate Specific Proteases [34]. The caspase gene family thus far contains at least 14 
mammalian members, of which 11 human enzymes are known [36]. Caspases and their 
homologues are known to be present in diverse species including nematodes, yeast, and 
dipterans [37,38]. 
The caspase family members share similarities in the amino acid sequence, structure and 
also the substrate specificity among each other [39]. They are synthesized as inactive 
zymogens in the cells and are activated either by autocatalytic processing initiated by 
adaptor-protein mediated aggregation or by proteolysis by other active caspases [40]. The 
proenzymes are around 30 to 50 kD in size and consist of three domains: a small subunit 
(~10 kD), a larger subunit (~20 kD), and an NH2-terminal
 domain [40]. The activation of 
the caspases starts with the proteolytic processing between the domains, followed by the 
formation of a heterodimer by association of the large and the small subunit. The NH-2 
domain varies highly in sequence and length, and has been shown to be important for the 





Caspases are extremely specific proteases, with an almost absolute requirement for 
cleavage after an aspartic acid in the substrate. There are some observed exceptions to this 
rule- some caspases can unusually cleave substrates after a Glutamate [41,42]. The 
cleavage site is also marked by the presence of at least four amino acids towards the NH2-
terminal of the site. The tetrapeptide recognition motif (designated as P4-P3-P2-P1) differs 
among caspases and could explain their functional diversity [43]. It has been seen that the 
P3 position is invariantly Glutamate for all mammalian caspases [40].  Thus the specificity 
of cleavage for mammalian caspases can be described as X-Glu-X-Asp. However, not all 
proteins containing the optimal tetrapeptide sequence are cleaved by caspases, implying 
that tertiary structural elements are also important for substrate recognition. This strict 
substrate specificity explains why apoptosis does not entail indiscriminate protein 
digestion, but instead consists of the cleavage of specific proteins in a coordinated fashion. 
The protease activity of the caspases is highly efficient (kcat/Km > 10
6 M-1 s-1) [40].  
Since caspases are potent proteases, they exist in the form of inactive zymogens with a 
very low enzymatic activity in healthy cells. The activation of caspases is tightly regulated 
within the cell. The cleavage of the proenzyme is seen to occur at caspase consensus sites, 
implying that the activation Caspases that are activated initially in response to apoptotic 
stimuli are called the “initiator caspases”, which include caspase-2, -8, -9 and -10. These 
can in turn activate the downstream “effector caspases”, which include caspase-3, -6 and -
7. An initiator caspase is characterised by an extended N-terminal prodomain (>90 amino 
acids) which is important for its function while the prodomain of an effector caspase has a 
short 20-30 residues (Thornberry and Lazebnik, 1998). 
They have been shown to get activated by an autocatalytic process after they are brought in 
close proximity to each other by adaptor proteins [44]. It has been shown that protein-
protein interaction motifs on the caspases viz. the Caspase Recruitment Domain (CARD) 
and the Death Effecter Domain (DED) interact with similar motifs present on the adaptor 
proteins to bring the caspases together for the autocatalytic activity [45]. Caspase-8 
activation occurs following sequestering by the adaptor protein Fas-Associated Death 
Domain (FADD) into the Death Inducing Signaling Complex, DISC [44]. Caspase-9 
similarly gets activated by forming a heteromeric complex, termed apoptosome with the 
adaptor protein Apoptotic Protease Activating Factor 1 (Apaf-1) [46]. The initiator 





which is required for the formation of the active site. Once activated, the initiator caspases 
can cleave and activate the effector caspases.  
The caspase activation is kept under tight control in the cell. The most prominent family of 
proteins involved in caspase inhibition is the Inhibitor of Apoptosis proteins, IAPs. 
1.2.2 The Inhibitor of Apoptosis Proteins 
The Inhibitor of Apoptosis Proteins constitute a family of proteins characterized by the 
presence of one to three Baculoviral IAP repeat (BIR) domains. The iap gene was first 
identified from insect cells infected with baculovirus, where the gene imparted apoptosis 
resistance in the host cell [47]. The characteristic BIR domain consists of around 70 amino 
acids containing the sequence CX2CX16HX6C. The BIR domains fold as a three stranded 
-sheet surrounded by four  Helices that form a hydrophobic core with a zinc ion at the 
centre. Some IAPs also have a RING (Really Interesting New Gene) domain at the C 
terminus. Examples of such IAPs include cIAP-1, cIAP-2 and XIAP. The RING domains 
can confer E3 ubiquitin ligase activity to the IAPs conferring to the self-regulation of the 
IAP proteins by degradation by the proteasome [48]. Other structures present in some IAPs 
are the Caspase Activation and Recruitment Domain (CARD), Phosphate loop and 
Ubiquitin-conjugating (UBC) domain.  
IAP family members are highly conserved homologs in diverse species ranging from 
viruses, yeast, nematodes, flies to higher vertebrates. In addition IAP like proteins, ILPs 
have been found even in plants, where they serve similar functions of apoptosis resistance 
[49]. XIAP, cIAP1 and cIAP2 are the best characterized mammalian IAPs, each containing 
three BIR domains and one RING domain.  
The three BIR domain subtypes, BIR1, BIR2 and BIR3 are responsible for mediating 
protein-protein interactions. Although they have an overall similarity, the individual BIR 
domains have specificities for distinct intermediates involved in different apoptotic and 
signalling pathways. BIR2 and BIR3 have been shown to bind directly and inhibit the 
proteolytic activity of caspases [50]. BIR2 selectively targets caspase-3 and caspase-7 
while BIR3 is specific for caspase-9 [51]. The caspase binding specificity of BIR2 and 
BIR3 domains in cIAP-1 and cIAP-2 is similar in extent [50]. All known RING containing 
IAPs have a ubiquitin ligase activity, targeting a variety of substrates involved in apoptosis 





catalyze their own ubiquitination in a RING dependant manner when subjected to certain 
apoptotic stimuli [52,53]. This autoubiquitination is an important regulatory step. It has 
also been seen that SMAC, once released into the cytosol during apoptosis, can similarly 
promote the polyubiquitination of cIAP-1 and cIAP-2 leading to their degradation [54,55].  
IAPs are best known for their function as apoptosis inhibitors. Early reports showed that 
IAPs could directly bind to caspases and inhibit their enzymatic activity [56,57]. In 
mammals, caspases-3, -7 and -9 are subject to inhibition by IAPs [58]. Overexpression of 
any one of IAPs, such as XIAP, cIAP-1 or cIAP-2 protects cells from apoptosis. It has 
been observed that although Caspase-9 binds to several IAPs, it is mainly inhibited by 
XIAP. On the other hand, caspase-3 and -7 are inhibited by XIAP and also by cIAP-1, 
cIAP-2 and NAIP [56,59]. XIAP is thus the most potent among the IAPs, with its BIR2 
domain and the linker between the BIR1 and BIR2 specifically binding to the IAP Binding 
Motif ( IBM ) of the active site on caspase-3 and -7 [60].   
The mechanisms of apoptosis inhibition of cIAP-1 and cIAP-2 are different from those of 
XIAP- although both of the former have a caspase binding scaffold, there is no significant 
caspase-inhibitory activity seen in in vitro experiments [50]. It appears that a BIR domain 
must have an IBM interacting groove as well as an inhibitory element to block caspase 
activity. However the RING domain on IAPs has been shown to impart an E3 ubiquitin 
Ligase activity. As such, the RING containing IAPs are known to aid the degradation of 
many proteins including caspase-3 and caspase-7. Interestingly, cIAP-1 and cIAP-2 are 
also known to undergo autoubiquitination and cross-ubiquitinate in a RING dependant 
manner during apoptosis [52,61].  
The role of IAPs in apoptosis inhibition is exemplified in the LPS treatment of 
macrophages derived from mice. Wild type macrophage cells have a transcriptional up-
regulation of cIAP-2 during LPS treatment and thus resist apoptosis. In contrast, c-IAP2 
knock out macrophages undergo rapid Fas-induced apoptosis upon LPS treatment [62]. In 
a normal healthy cell, the constitutive levels of IAPs are not sufficient to antagonize 
apoptotic signals. However, when expressed in high levels, the IAPs are able to effectively 
block apoptosis.  
1.2.3 Pathways of Apoptosis 
Apoptosis induction and subsequent caspase activation occurs through two main pathways 





third route is involved in cytotoxic T cell-mediated apoptosis initiated by 
perforin/granzyme (Figure.1).  
 
Fig. 1: The three pathways of apoptosis initiation. Apoptosis can be mediated via three pathways, 
the extrinsic or death receptor mediated pathway, the intrinsic or mitochondria-mediated pathway 
and the Granzyme B/Perforin pathway. Binding of death ligands to their specific death receptor 
leads to the activation of the extrinsic pathway by forming a complex where caspase-8 gets 
processed and activated. Activated caspase-8 can either directly cleave and activate caspase-3 in 
Type I cells or in Type II cells it can initiate the intrinsic pathway by cleaving Bid, a BH3-only 
domain protein. The intrinsic pathway can also be initiated by other BH3-only proteins (such as 
Bid, Bim, Bmf that get activated in response to specific stress signals in the cell. This leads to the 
activation of Bax/Bak which triggers mitochondrial membrane permeabilization causing the release 
of pro- and anti-apoptotic factors into the cytosol. These factors form the apoptosome consisting of 
cytochrome C, Apaf-1 and caspase-9 to trigger caspase-3 activation. This process can be inhibited 
by antiapoptotic Bcl-2 proteins like Mcl-1, Bcl-2 or Bcl-XL. Smac released by the mitochondria is 
required to reverse the inhibition of the caspase activation by the IAP complexes in the cytosol. 
Finally, in the Granzyme B pathway, perforin and granzyme B are released by cytotoxic T-





membrane with the aid of perforin, and once inside the cell it can directly activate caspase-3 or 
initiate the mitochondrial step described above. 
 
 
Extrinsic Pathway: In the extrinsic pathway, apoptosis is initiated when death ligands 
bind to a transmembrane receptor on the cell surface. The death receptors belong to the 
tumor necrosis factor (TNF) receptor gene superfamily [63]. Some of the well known 
receptors and their ligands are FasL/FasR, TNFα/TNFR1, Apo3L/DR3, Apo2L/DR4 and 
Apo2L/DR5. In the extensively characterized FasL/FasR and TNFα/TNFR1 systems, 
clustering of the receptors occurs together with the binding of the homologous trimeric 
ligand [64]. Consequently, cyctoplasmic adapter proteins get recruited to the 
receptor/ligand complex through their death domains. The binding of TNF to the TNF 
receptor, with a simultaneous block in protein synthesis, results in the binding of TRADD 
(TNF receptor 1-associated protein) with FADD (Fas-Associated protein with Death 
Domain) and RIP [65,66]. Binding of TNF to TNFR1 can lead to the activation of 
nuclear factor B (NFB) when protein synthesis is not blocked [67]. Procaspase-8 is then 
recruited to the complex, where it binds to FADD through dimerization of the death 
effector domain. This complex is called the Death Inducing Signalling Complex, DISC. 
Procaspase-8 gets autocatalytically cleaved and activated at the DISC, via a proximity 
induced activation model [68]. At this stage death receptor mediated apoptosis can be 
inhibited by a protein called FLICE/caspase-8 Like Inhibitory Protein (c-FLIP) which can 
bind to FADD and caspase-8 [69]. In healthy tissues, decoy receptors, closely related to 
TRAIL, are expressed to compete with the death receptors for binding with the ligand [70].  
In Type I cells, the amount of activated caspase-8 is high enough to directly activate 
caspase-3 which leads to apoptosis. However, in Type II cells, FADD recruitment to the 
DISC and the subsequent generation of active caspase-8 is too little to directly cleave 
caspase-3 for apoptosis [71]. In these cells, Bid gets activated by caspase-8 and this in turn 
activates the mitochondrial pathway to initiate apoptosis [72]. Blocking of the 
mitochondrial pathway, for example by overexpression of Bcl-2 or in absence of Bax/Bak, 
results in blocking of apoptosis in Type II cells but not in Type I cells. 
Intrinsic pathway: A diverse range of non-receptor mediated stimuli can also elicit 





infections. The intrinsic pathway can also be initiated directly by the absence of certain 
growth factors, hormones or cytokines which leads to a failure in the suppression of the 
death pathways. Each of these stimuli activates a specific BH3 only protein that acts as a 
sensor to that cellular stress [73]. The BH3 only proteins Bid, Bad, Bim, Bik, Noxa and 
Puma belong to the Bcl-2 family and are characterized by the Bcl-2 homology domain 3. 
As described in detail below, the Bcl-2 family of proteins is extensively involved in 
regulating the intrinsic pathway of apoptosis.  
The active BH3-only proteins lead to the activation of Bax/Bak and this process is 
inhibited by the antiapoptotic Bcl-2 members like Mcl-1. Bax/Bak are responsible for the 
mitochondrial outer membrane permeabilization causing the release of apoptogenic factors 
including cytochrome c and SMAC into the cytosol. Cytochrome c binds and activates the 
cytosolic Apaf-1 and procaspase-9 forming a complex called apoptosome [74]. Active 
caspase-9 can then activate caspase-3. 
 
Perforin/granzyme Pathway: In the Granzyme B pathway, perforin and granzyme B are 
released by cytotoxic T lymphocytes when they recognize antigen bearing cells. Granzyme 
B is exophytically released through the plasma membrane with the aid of the 
transmembrane-pore forming protein perforin. Once inside the cell it can directly activate 
caspase-3 or initiate the mitochondrial step described above.  
Granzyme B can cleave proteins at aspartate residues and thus activate procaspase-10 and 
can cleave factors like Inhibitor of Caspase Activated DNAse (ICAD) [75]. Granzyme B 
can also initiate the mitochondrial pathway by specific cleavage of Bid  but also directly 
activate caspase-3 inducing apoptosis [76].  
1.2.4 Bcl-2 family of proteins 
The Bcl-2 (B-cell lymphoma-2) gene was discovered at the t(14;18) chromosome 
translocation breakpoint in B-cell follicular lymphomas [77,78]. It was observed that 
overexpression of the gene strongly inhibited cell death by apoptosis, which is a prominent 
tumour suppression mechanism. Since then it has been found that the Bcl-2 family of 
proteins are required for a range of apoptotis related activities including developmentally 
programmed cell death, tissue turnover and host defence against pathogens.  
There are at least 20 mammalian Bcl-2 family members, all of which share at least one 





into three groups based on their role in either apoptosis activation or inhibition. The first 
group is characterized by the presence of BH domains BH1-4. This group comprises all 
anti-apoptotic members including Bcl-2, Bcl-XL, Bcl-W, Mcl-1, Bcl-B (also known as Bcl-
2L10) and A1. A second group contains proapoptotic members which have the domains 
BH1 -3 including Bax, Bak and Bok. A third group contains also proapoptotic members, 
but with only the BH3 domain. Members of this group are Bid, Bad, Bik, HRK, Bim, Bmf, 
NOXA and PUMA which can bind and regulate the anti-apoptotic Bcl-2 proteins to 
promote apoptosis.  
 
BH3 only proteins 
BH3-only proteins are defined as having homology to the core Bcl-2 family members in 
only the BH3 domain. These proteins act as sensors to certain cellular stresses, in response 
to which they get activated and transduce the apoptotic signal to activate Bax and Bak 
which in turn can activate the mitochondrial pathway [80]. Bim is required for the removal 
of auto-reactive B- and T-cells and thus has a role in preventing autoimmunity [73,81]. It is 
also induced by growth factor deprivation by the class O forkhead box transcription factor-
3A (FOXO3A) or by the transcription factors CEBP- (CCAAT-enhancer binding protein-
) or CHOP (CEBP homologous protein) in response to endoplasmic reticulum (ER) stress 
[82,83]. Puma and Noxa are transcriptionally up-regulated by p53 in response to DNA 
damage [84,85]. Puma is also required for apoptosis induction in lymphocytes induced by 
cytokine withdrawal, or treatment with glucocorticoids, phorbol ester, or staurosporine 
[86,87]. Bad is activated by loss of phosphorylation in mammary epithelial cells in the 
absence of epidermal growth factor (EGF) while Bid is required for apoptosis of 
fibroblasts and hepatocytes induced by death receptors [88,89]. Bmf has been shown to 
have a role in detachment induced apoptosis, termed anoikis in certain cell types. Bim and 
Bmf are initially associated with the microtubules and the actin cytoskeleton respectively 
via interaction with a Dynein Light Chain (DLC) and their release can induce apoptosis 
[90]. 
In an elegant study, Wei et. al. showed that cells lacking both Bax and Bak and not cells 
lacking only one of these, are fully resistant to cytochrome c release and apoptosis induced 
by tBid [91]. Similar results were reported by Zong et. al. who showed that activated BH3 





became clear that Bax and Bak are required for apoptosis induction and lie downstream of 
the BH3 only proteins in the pathway.  
 
Bax and Bak 
Bax mainly resides in the cytosol of healthy cells as a soluble monomeric protein. In 
response to apoptotic stimuli, Bax undergoes conformational changes at both its N- and C- 
terminus and translocates to the mitochondrial outer membrane where it forms large 
oligomeric complexes. In contrast, Bak is constitutively associated with the outer 
mitochondrial membrane, where it changes its conformation in response to apoptotic 
stimuli and also forms oligomeric complexes [93,94,95]. Once the Bax and Bak oligomers 
are formed, mitochondrial permeabilization occurs, culminating in the release of  
proapoptotic factors into the cytoplasm (reviewed in [96]). Simultaneously with 
cytochrome c release or immediately before, Bax and Bak induce mitochondria to 
fragment into more numerous and smaller units suggesting that the Bcl-2 family could 
have a role in mitochondrial division processes [97]. 
It is known that the Bax/Bak activation is controlled by other members of the Bcl-2 family, 
though the exact mechanism remains unclear. Huang et. al. proposed a model in which all 
BH3-only proteins can bind Bcl-2 pro-survival proteins and a select few such as Bim, tBid, 
and possibly Puma also have the capacity to directly bind and activate Bax and Bak. Bax 
and Bak cannot be activated in the absence of the “direct activator” group of Bim, tBid or 
Puma. However, other BH3 only proteins called the “derepressors” (Bad, Bik, Hrk, Noxa) 
that cannot activate Bax and Bak on their own, can induce apoptosis by binding to the pro-
survival proteins and freeing the direct activators [98].   
It is known that some of the BH3 only proteins such as Bim, Puma are more potent 
apoptosis inducers compared to other members like Bad or Noxa. Studies measuring the 
affinity of peptides corresponding to the BH3 domains of the established mammalian BH3-
only proteins to their Bcl-2 pro-survival partners showed that Bim and Puma bind with 
high affinity to all pro-survival members, while the others have more restricted binding 
profiles [99]. These results suggested that each of the Bcl-2 prosurvivial proteins might 
have a unique role in antiapoptosis, and that each of these different classes must be 
neutralized to induce apoptosis. This was further confirmed when it was observed that co-





which neutralizes Mcl-1 and A1, and Bad which neutralizes Bcl-2, Bcl-xL, and Bcl-w, 
induced apoptosis to a similar extent as the expression pan-specific BH3-only protein Bim 
did [99].  
 
1.2.5 Pro-survival Bcl-2 proteins 
The Bcl-2 pro-survival proteins act by directly interacting with Bax and Bak at the 
mitochondrial outer membrane. Bak forms complexes with both Mcl-1 and Bcl-xL, by 
interacting through its BH3 domain, but not other pro-survival proteins such as Bcl-2 
[100]. Thus Mcl-1 and Bcl- XL sequester Bak in healthy cells and are both important 
inhibitors of Bak activation and subsequent mitochondrial damage. This is further 
confirmed by the fact that Noxa expression does not kill wild type cells because it can only 
neutralize Mcl-1 and not Bcl-XL, it efficiently induces apoptosis in cells lacking Bcl-XL. 
On the other hand, Bax was observed to bind to Bcl-2 after Bax translocates to the 
mitochondria following a confirmational change [101]. 
1.3 Myeloid Cell leukaemia-1 
Myeloid Cell Leukemia sequence 1 (Mcl-1) was identified as an early induction gene 
during myeloblastic cell differentiation. Mcl-1 is one of the most important anti-apoptotic 
proteins preventing inappropriate activation of Bax and Bak in healthy cells [102]. Mcl-1 is 
critically required during embryonic development with its deficiency resulting in peri-
implantation embryonic lethality [103]. Mcl-1 is also required for the survival of 
hematopoietic stem cells and in the development of B- and T- lymphocytes [104,105]. 
Mcl-1 contains a C-terminal transmembrane (TM) domain that results in localisation of 
Mcl-1 to various intracellular membranes, most notably the outer mitochondrial membrane 
[106]. There it is known to sequester Bak and maintain it in an inactive state in healthy 
cells. Because of its strong anti-apoptotic effect, Mcl-1 is required to be removed or 
neutralized for apoptosis induction. It is degraded in a proteasome dependant manner 
during apoptosis induction by genotoxic agents like UV radiation or by over-expression of 
BH3 only proteins. When Mcl-1 degradation is blocked using inhibitors, the apoptosis rate 
is decreased [99,107].  
The expression of Mcl-1 is tightly regulated because of its vital role in cell survival and 





factors regulate Mcl-1 levels in the cell [108]. Survival pathways like Mitogen-activated 
protein kinase (MAPK), phosphatidylinositol-3 (PI3K) and Janus kinase (JAK)/signal 
transducer and activator of transcription (STAT) dependant pathways have all been 
implicated in controlling of Mcl-1 transcription, acting via specific transcription factor 
response elements in the Mcl-1 promoter [108,109]. However, Mcl-1 expression as well as 
function is also controlled by posttranslational modifications including direct 
phosphorylation [110].  
Recently, it was shown that HIF-1 has an anti-apoptotic effect that is mediated via Mcl-1 
expression [111,112]. It was seen that the transcription factor, HIF-1 controls the 
expression of Mcl-1 during hypoxia. When the regulatory subunit of HIF-1 was 
downregulated by silencing with RNAi, the mRNA levels of Mcl-1 were also reduced. It 
has also been shown that the Mcl-1 gene promoter has a hypoxia responsive element 
(HRE) that can bind HIF-1 in vitro [111].  
1.4 Hypoxia Inducible Factor-1  
Hypoxia Inducible transcription Factors, (HIF) are a family of transcription factors that are 
crucial mediators of the oxygen signaling pathways in a cell. These are heterodimeric, 
consisting of an oxygen-sensitive alpha subunit (HIF-) and a constitutive beta subunit 
(HIF-). The HIFs facilitate both oxygen delivery and adaptation to oxygen deprivation by 
regulating the expression of genes that control glucose uptake, metabolism, angiogenesis, 
erythropoiesis, cell proliferation, and apoptosis [113].  
HIF-1 was the first member of the HIF-1 family to be discovered - originally 
characterized as a biologic O2 sensor that enables the organism to adapt to hypoxia [114]. 
HIF-1 has emerged as the most important regulator of cellular response to hypoxia since it 
is ubiquitously expressed and induces the expression of many hypoxia-inducible genes. At 
the cellular level, HIF-1 induces the expression of virtually all glycolytic enzymes, genes 
involved in erythropoiesis, pro-angiogenic genes, such as vascular endothelial growth 
factor (VEGF) and anti-apoptotic genes including mcl-1 and cIAP-2 [112,115,116].   
In its active form, HIF-1 is a heterodimer composed of an  subunit (100–120 kDa) and a 
 subunit (91–94 kDa). While HIF-1β is permanently present in cells under all oxygen 
conditions, HIF-1α is virtually undetectable in normal oxygen conditions, since it gets 





functional, HIF-1α levels must be induced. Under hypoxia, HIF-1α gets stabilized and 
binds to HIF-1β in the nucleus to form the HIF-1 transcription complex. Interestingly, it 
has been shown that HIF-1 activity can be increased through phosphorylation. HIF-1 is 
directly phosphorylated by p42/p44-mitogen-activated protein kinases (p42/p44-MAPK). 
Activation of the p42/p44-MAPK pathway leads to increased transcriptional activity of the 
HIF-1 complex and downstream gene activation [117].  
1.4.1  HIF-1 and anti-apoptosis 
Under severe hypoxic conditions some cells are irreversibly damaged, whereas mild 
hypoxia can lead to cells adapting to the stress and becoming resistant to injury 
[118,119,120]. Cells that become adaptive to hypoxia are more resistant to apoptosis and 
less responsive to cancer therapy [121]. The anti-apoptotic effect of hypoxia arises due to 
the increased expression of pro-survival factors in the hypoxic cells. Dong et al. reported 
that cells grown under hypoxic conditions were resistant to staurosporine induced 
apoptosis. It was observed that the hypoxia induced increased levels of cIAP-2 in the cells, 
which was required for the apoptosis inhibition [122].  
The anti-apoptotic effect of HIF-1 was also demonstrated by Liu et. al., who reported that 
HIF-1 regulated the levels of Mcl-1 in airway epithelial cells. The cells were susceptible 
to apoptosis induced by anoxia/reoxygenation when either HIF-1 or Mcl-1 levels were 
decreased by RNAi [112]. Park et. al. showed that human lung carcinoma A549 cells 
exposed to hypoxia were significantly protected against TRAIL induced apoptosis [123]. 
1.4.1 HIF-1 stabilization during Chlamydia pneumoniae infection 
It has been reported that Chlamydia pneumoniae interferes directly with HIF-1 regulation 
in the infected cell. During hypoxia, the infection had an additive effect on HIF-1 
stabilization and HIF-1 activation. However, during late phase of intracellular Chlamydia 
replication (48 h) HIF-1 was seen to be degraded by the activity of the chlamydial 
protease-like activity factor (CPAF) secreted into the cytosol of the infected cells. It was 
also observed that HIF-1 was required for the efficient C.pneumoniae replication during 
hypoxia [124]. These data show that HIF-1 is targeted by the chlamydiae to control host 






1.5 Apoptosis in defence against infections 
Apoptosis plays an important role in embryogenesis, development of the nervous and 
immune systems, and tissue homeostasis. In addition, it constitutes a vital defence 
mechanism against damaged or infected cells. Cytotoxic T lymphocytes can kill tumour 
cells or virus infected cells by inducing apoptosis [125]. Apoptosis is induced in infected 
cells and the resulting apoptotic bodies phagocytosed, thus preventing the spread of 
infection to neighbouring cells. For example, it has been shown that the programmed cell 
death of Mycobacterium avium infected cells is an important defence mechanism, which 
acts by sequestering Mycobacteria and aids in their killing by activation of newly recruited 
macrophages [126]. 
Resistance to apoptosis in the infected cells is therefore important for pathogens, especially 
those residing inside the cell, to evade the host immune response. Several parasitic 
pathogens, including viruses and bacteria, modulate host cell apoptosis to escape from the 
host cell immune response and prolong their stay in the host. Bacteria like Salmonella, 
Shigella and Yersinia spp., defend themselves from host macrophages by inducing 
apoptosis [127]. Others like Helicobacter, Neisseria, Staphylococcus and Listeria spp. 
induce cell stress by bacterial toxins or effector proteins, resulting in apoptosis of the host 
cell  [128,129,130,131]. 
 
1.6 Chlamydia and apoptosis 
Obligate intracellular bacteria like Rickettsia spp. or Chlamydia spp. confer resistance to 
the host cell against a variety of apoptotic stimuli, including the action of cytotoxic T-cells 
[132,133].  The bacteria are thus able to maintain a long term relationship inside the host 
cell. In case of Chlamydia spp., this could help the bacteria to complete its replication 
cycle inside the cell, at the end of which numerous elementary bodies are produced and 
released to infect other host cells. Chlamydia can sometimes develop long term chronic 
infections that could contribute to diseases like atherosclerosis or cancer. Protection of the 
host cell against apoptosis would acquire greater significance for the bacteria under such 
conditions. It is not surprising therefore, that persistently infected cells have also been 





Although apoptosis inhibition by Chlamydia has been widely reported, there have also 
been reports of induction of apoptosis by Chlamydia [136,137,138]. However, subsequent 
studies have confirmed that Chlamydia has a predominantly anti apoptotic effect and that 
the “Chlamydia induced cell death” is different from apoptosis, although some of the 
morphological features may be similar [139,140,141]. In the background of the block in 
the apoptotic pathways during infection, this cytotoxicity might be the result of cell stress 
and damage mediated by the host innate immune reaction or by the bacteria itself. The 
presence of a bacterial inclusion in the cell would inevitably cause damage and stress in the 
cell, and it is not surprising that some cells die under the circumstances- the cell is after all 
still mortal, and although it cannot be forced to commit suicide, it can still be murdered! 
Chlamydia has evolved various strategies to survive intracellularly, whereby it not only 
prevents the detection of the host cell by the immune system, but also protects it from 
destruction by the immune mechanism in case of recognition. The bacteria can down-
regulate the expression of MHC Class I and II molecules, thus avoiding the recognition of 
the host cell by CD + T cells [142],[143]. Chlamydia further protects the host cell against 
cytoxic immune response, by its remarkable ability of making the cell strongly resistant to 
apoptosis.  
Apoptosis resistance has been attributed to all major chlamydial species viz. 
C. pneumoniae, C. trachomatis, C. psittaci, C. muridarum, as well as C  caviae, 
[133,144,145,146]. Of these C. trachomatis and C. pneumoniae have been widely studied 
for their strong anti apoptotic effect and relevance to human diseases.  
The chlamydial infection protects cells against different forms of apoptosis described 
above such as the extrinsic, the intrinsic and the granzyme B pathway, mediated by various 
stimuli including staurosporine, tumor necrosis factor alpha, etoposide, granzyme 
B/perforin, and UV light [133,144,147]. Initial work characterizing the apoptosis resistance 
showed that only the inclusion carrying cells were protected, in contrast to any uninfected 
neighboring cells, suggesting that the effect was conferred by the intracellular bacteria and 
not through a factor secreted into the medium [144]. Further, chlamydial protein synthesis 
has been shown to be essential for the effect since treating the cells with the prokaryotic 
transcription inhibitor rifampin or the translation inhibitor chloramphenicol abrogated the 





in the presence of the eukaryotic translation inhibitor cycloheximide, host cell synthesis 
was not required for apoptosis inhibition [133].  
Analysis of the apoptotic pathway in the infected cell showed that there was a block in the 
release of cytochrome c from the mitochondria into the cytosol. Cytochrome c is required 
for the activation of the procaspase-9 through apoptosome formation. Caspase-9 eventually 
cleaves and activates caspase-3. Expectedly in the infected cells, there was no 
processing/activation of caspase-9 or caspase-3 [148].  This implied that there was a block 
in the mitochondrial permeabilization, which in turn is controlled by Bax and Bak. Later 
studies showed that the chlamydial infected cells failed to achieve the activation of these 
regulators of mitochondrial permeabilization [149,150]. It was further shown that the 
infected cells are not resistant to apoptosis in type 1 cells, which do not require the 
mitochondrial pathway for activation of the effector caspases [151]. With these data it 
became evident that Chlamydia confers a block at the mitochondrial level. This would also 
explain the resistance to apoptosis initiated through different pathways that collude at the 
mitochondria.  
It has been reported that during chlamydial infection, there is a broad scale degradation of 
the different BH3-only proteins in the cell. The mRNA levels of these proteins were not 
affected, indicating that the down-regulation was at the protein level. The Chlamydial 
protease-like activity factor (CPAF) was shown to be responsible for targeting those active 
proteins with an exposed BH3 domain, for degradation [150,152,153,154], implying that 
Chlamydia destroy most, if not all, active BH3-only proteins. In absence of the BH3-only 
proteins, death signals cannot be transmitted to the mitochondria, and this could account 
for the block in apoptosis upstream of the mitochondria. 
In an elegant experiment to analyse the extent of apoptosis inhibition in the infected cells, 
it was noticed that the cytosolic extract from chlamydial infected cells resisted the 
activation of caspase-3 even on treatment with cytochrome c [155]. This indicated that 
Chlamydia infected cells have a block in apoptosis downstream of the mitochondria as 
well, that would prevent the activation of caspases in spite of cytochrome c release. 
Evidently, Chlamydia interfere with the host apoptotic machinery at different levels- not 





Genetic studies in the infected cells showed that Chlamydia indeed widely interferes with 
the host protein synthesis. Infection with C. trachomatis led to the up-regulation of some 
genes including certain anti-apoptotic genes such as c-IAP2 [156,157,158,159].  
Chlamydial infection has been reported to activate certain survival pathways in the cells 
including the MAPK and the PI3K pathways [160]. The activation of the PI3K pathway in 
the infected cells has also been shown to sequester the BH3-only protein BAD away from 
the mitochondria. It was seen that activation of the PI3K pathway led to the 
phosphorylation of BAD after which it was recruited to the surface of the chlamydial 
inclusion [161]. This would further increase the resistance to those apoptosis inducers (e.g. 




2.1 Characterization of apoptosis resistance in cells infected with 
Chlamydia trachomatis  
All major chlamydial species have been reported to inhibit apoptosis. In the present work 
Chlamydia trachomatis was considered due to its relevance to human diseases and also 
because of the feasibility in working with it in the laboratory.  
2.1.1  C. trachomatis inhibits apoptosis induced by different stimuli 
Cells infected with Chlamydia strongly resist apoptosis induced via the intrinsic pathway, 
induced for example by DNA damage by cisplatin or thapsigargin or the death receptor-
mediated pathway induced by TNF-/CHX Figure 2A. A time lapse microscopy 
experiment with HeLa cells infected with Chlamydia and treated with TNF-/CHX 
showed that only the cells carrying inclusions were protected from apoptosis as shown in 
Figure 2B. Neighbouring cells without a chlamydial inclusion undergo apoptosis on 
treatment- this can be observed as the rounding up of the apoptotic cells in the image. This 
suggests that an active growth of Chlamydia inside the cell is required for apoptosis 
resistance, and that no effector secreted into the medium is responsible for protecting cells. 
The immunoblot in Figure 2B shows the level of apoptosis in the infected cells compared 
to that in non-infected cells which were also treated similarly with TNF-/CHX. Cleavage 
of Poly (ADP-ribose) Polymerase (PARP) occurs during apoptosis induction and was seen 






Fig. 2: Cells infected with Chlamydia trachomatis resist apoptosis. A: HeLa cells were infected 
with Chlamydia trachomatis (lower panel) or left uninfected (upper panel) and treated with 
different inducers of apoptosis- Cisplatin, Thapsigargin, and TNF-/CHX. Phase contrast pictures 
of the cells show the extent of apoptosis in the infected and non infected cells. The dead cells can 
be observed as the bright rounded up cells. B: Images from time lapse microscopy showing HeLa 
cells infected with C trachomatis and treated with TNF-CHX (right picture) at the indicated time 
points. The arrows point at chlamydial inclusions. The extent of apoptosis was quantified in 
similarly treated cells by probing for PARP cleavage. Bacterial Hsp60 (CHSP60) was probed to 
show the extent of chlamydial infection. 
 
2.1.2 Activation of caspase-3 was inhibited in Chlamydia-infected cells 
During apoptosis, caspase-3 gets cleaved at the aspartic acid residue D175 to yield a small 
subunit and an N-terminal p19 fragment that contains the prodomain. The prodomain is 
subsequently cleaved off autocatalytically at the N-terminal fragment yielding a p17 
fragment. The fully active caspase-3 is characterized by the presence of these p19 and p17 
fragments [162]. During late apoptosis the conversion of the p19 fragment to the p17 




caspase-3 during infection, a time course of infection was done. At each time point 
apoptosis was induced with TNF-CHX and proteins were isolated for immunoblot after 
5 h and 10 h post apoptosis induction. Caspase-3 blots revealed that in the uninfected cells, 
caspase-3 was cleaved to the p19 and p17 fragments as seen after 5 h (Figure 3). After 10 h 
of apoptosis induction, the p17 fragment is predominantly visible, showing the extensive 
autocatalytic activation of the cellular caspase-3. However, in the Chlamydia infected cells, 
the generation of the p17 fragment after apoptosis induction was observed to be inhibited. 
The block in caspase-3 activation appears with the growth of the chlamydial inclusion in 
the cell around 20 h post infection. After 30 hours of infection, there is no appearance of 
the p17 fragment even after 10 hours of apoptosis induction. This shows that Chlamydia 
render a robust block in the caspase-3 activation during apoptosis induction. 
 
 
Fig. 3: Immunoblot of Caspase-3 processing during apoptosis induction. HeLa cells were infected 
with C. trachomatis (Ctr) for 10, 20 or 30 h (Inf. Time) or left uninfected and treated with TNF-
/CHX for 5 or 10 h (Tr. Time). Cleavage of caspase-3 to the full active p17 – fragment was 
abrogated in infected cells 20 h post infection. 
2.1.3  Caspase-8 was processed in Chlamydia infected cells upon apoptosis 
induction 
HeLa cells were infected with Chlamydia trachomatis or left uninfected and apoptosis 
was induced with TNF-CHX at various time points of infection. Procaspase-8 (p60) gets 
activated by autocatalytically cleaving to a p43/41 proform which is further processed to 
the active p18 fragment. As is seen Figure 4A the processing of caspase-8 was not altered 
by the chlamydial infection suggesting that the apoptotic block mediated by C. trachomatis 
does not occur at the step of the initiator caspases. 
Bid gets activated by cleavage to a truncated form, called tBid, by active caspase-8 during 
apoptosis induction by TNF-CHX. To check if Bid gets cleaved in Chlamydia infected 




induced to apoptosis with TNF-/CHX or left untreated. As can be seen in Figure 4B 
TNF-CHX treatment leads to the cleavage of Bid in uninfected and infected HeLa cells. 
This result further confirms that C. trachomatis did not inhibit the activation of caspase-8 
and did not inhibit the cleavage of Bid.  
 
Fig. 4: Caspase-8 is processed normally during apoptosis induction in infected cells.. 
A: Cells were infected with C. trachomatis (Ctr) for the indicated time points and treated with 
TNF-/CHX for 5 h. Full size caspase-8 and the cleaved caspase-8 fragments - p43/41 and p18 
were probed by immunoblotting. Caspase-8 was normally processed in infected cells. B: Infected 
and non infected cells were treated with TNF-/CHX and probed for levels of unprocessed BID. 
Only the proform of Bid was detected in the immunoblot which was reduced in uninfected (third 
lane) and infected (Ctr, fourth lane) cells induced to apoptosis (upper blot). The lower blot shows 
the equal loading control. 
 
2.2 The Inhibitor of Apoptosis Protein – complexes are required for 
apoptosis resistance in Chlamydia trachomatis infected cells  
It was observed that Chlamydia infected cells have normal caspase-8 activity upon 
treatment with TNF-/CHXHowever, there was a block in the complete processing of 
caspase-3 as was seen by the accumulation of the caspase-3 p19 fragment in Figure 3. This 
suggests a possible involvement of the Inhibitor of Apoptosis Proteins (IAPs), which have 





2.2.1  cIAP-2 expression is up-regulated during an infection with C. trachomatis 
HeLa cells were infected with C. trachomatis for 24 h or left uninfected and the mRNA 
expression of different IAPs was determined by quantitative real-time PCR (Figure 5A)1. It 
was observed that the mRNA level of cIAP-2 was increased considerably, whereas the 
levels of cIAP-1, XIAP or survivin did not change noticeably post infection. 
With immunoblot analysis it was seen that the protein levels of cIAP-2 and survivin were 
increased significantly, whereas the levels of XIAP and cIAP-1 remained more or less 
constant Figure 5B. Further time course studies revealed a time dependent up-regulation of 
cIAP-2 and survivin 24 h post infection Figure 5C. Significantly, the increase in the levels 




Fig. 5: cIAP-2 expression is up-regulated after chlamydial infection. HeLa cells were infected with 
C. trachomatis (Ctr) or left uninfected. A: The mRNA expression was determined 24 h post 
infection. B: Protein levels of different IAPs 24 hrs post infection, cIAP-2 and survivin are heavily 
up-regulated 24 h post infection. C: A time course of infection revealed an up- regulation of cIAP-
2 and survivin protein 24 h post infection. 
   
                                                 




2.2.2  IAPs are required for apoptosis resistance in the infected cells 
In order to elucidate the importance of the up-regulation of cIAP-2 in C. trachomatis 
infected cells cIAP-2 was knocked down with small interfering RNAs (siRNAs). HeLa 
cells were transfected with two different siRNAs against cIAP-2 (sicIAP-2) and a control 
siRNA against luciferase (siLuc) and infected with C. trachomatis or left uninfected. 24 
hours post infection, the cells were treated with TNF-/CHX to induce apoptosis. 
Apoptosis was measured by estimating the cleavage of caspase-3 by immunoblotting.  
It was observed that the knock down of cIAP-2 sensitized the infected cells to apoptosis. 
Interestingly, the caspase-3 immunoblot showed that in the absence of cIAP-2, the 
processing of procaspase-3 into the cleaved caspase-3 fragments – p19 and p17 – occurred 
normally in the infected cells (Figure 6). The relative levels of the p19 and p17 fragments 
give an idea of the extent of apoptosis in a cell. Therefore, these levels were determined by 
densitometric analysis in the cIAP-2 knock down samples and compared to in the control 
samples. In infected control cells, there was a 58 % reduction in the generation of the p17 
fragment as compared to the non-infected cells, upon apoptosis induction. After cIAP-2 
knock down, there was only a reduction of 29 % in the p17 fragment generation, when the 
infected cells are compared to the non-infected cells. This demonstrates a 50 % increase in 
the p19 to p17 conversion, upon cIAP-2 knock down, thus hinting at an important role of 
cIAP-2 in regulating the complete processing of the effector caspase-3.  
 
Fig. 6: Caspase-3 is processed normally in Ctr. infected cells with cIAP-2 knock down. Control and 
cIAP-2 knock down cells were infected (Ctr) and treated with TNF-/CHX.  Levels of cleaved 
caspase-3 were checked by immunoblotting of the different lysates. The block in the conversion of 
the p19 to p17 fragment in the infected cells is observed to be reversed in the absence of cIAP-2. 





In a similar experiment, siRNAs against cIAP-1, XIAP and survivin were also designed 
and the effect on apoptosis induction in the infected cells checked. Surprisingly it was 
noticed that knocking down of cIAP-1 and XIAP (and not of survivin) lead to a 
sensitization to apoptosis, even though it had been observed earlier that the levels of these 
two IAPs are not increased during the chlamydial infection (Figure 7) 1. The results were 
confirmed with a different set of siRNAs, to rule out any off-target effects of the first set of 
siRNAs. These experiments showed that the multi-BIR-containing IAPs viz. cIAP-1, 
cIAP-2 and XIAP have a role in apoptosis resistance in the infected cells.  
 
Fig. 7: Knock down of IAPs sensitizes infected cells to apoptosis. HeLa cells with RNAi mediated 
knock down of IAPs or Lamin control were infected with Ctr. and treated with TNF-/CHX. The 
rates of apoptosis were measured by a TUNEL assay. Loss of cIAP-1, cIAP-2, XIAP but not 
Survivin sensitized the infected cells to apoptosis. 
 
2.2.3 IAPs interact with each other, existing in large heteromeric native 
complexes 
The fact that although only cIAP-2 is overexpressed in the infected cells, but still the cell 
gets sensitized to apoptosis in the absence of the other IAPs, shows that these proteins 
might work in a concerted fashion- requiring the presence of each other for full 
functionality. Previous reports have shown that the IAPs can interact with each other. To 
confirm the formation of IAP complexes in our system, gel filtration analysis was 
performed. It was important to exclude the presence of mitochondrial Smac from the 
sample before the interaction of IAPs could be measured. Smac is known to interact and 
bind to the different IAPs. This could lead to the appearance of the IAPs in high molecular 
weight fractions. Smac is localized in the mitochondria of non-apoptotic cells. Therefore, 
                                                 




before gel filtration, the mitochondria were separated from the cytosol by cell 
fractionation, and only the cytosol was used for further analysis. The cytosol of HeLa cells 
was isolated by subcellular fractionation and the proteins separated by gel filtration. The 
different fractions were probed for the presence of certain IAPs by immunoblotting. cIAP-
1, cIAP-2 and XIAP were found to be present in fractions containing eluates of around 400 
kDa in size (Fig.8). The proteins were also eluted in fractions representing their 
monomeric forms (around 50-60 kDa).  Survivin was mainly detected in a low molecular 
weight fraction, consistent with its monomeric size (Fig.8).  
 
Fig. 8: IAPs are organized in high molecular weight complexes. Subcellular fractions from the 
cytosol of HeLa cells were separated by gel filtration as described in Materials and Methods 
section. The presence of IAPs in each fraction was checked by immunoblot analysis. The fraction 
numbers in the figure are marked with the approximate size of the proteins (and complexes) eluted 
in the fraction. The numbers on the top represent the fraction number, with the molecular weight 
range of the proteins eluted. 
2.2.4  The formation of IAP complexes is not cell type specific 
In order to investigate if the presence of IAP complexes was restricted only to HeLa cells, 
Hec1b and Jurkat cells were also subjected to gel filtration. The same IAP complexes were 
also present in Hec1b and Jurkat cells. When the cytosolic fractions of Hec1B or Jurkat 
cells were analysed by gel filtration, cIAP-1, cIAP-2 and XIAP were observed in high 






Fig. 9: IAP complexes are detected in different cell types viz. A: Gel filtration studies with  Hec1B 
cells. The lower panel shows the original cIAP-1 immunoblot from the upper panel, which was cut 
for compiling with the blots for XIAP and cIAP-2. HA refers to whole cell lysate.   
B: Gel filtration studies on Jurkat cells. The IAP-IAP complexes are observed in the Jurkat cells 
also. 
 
2.2.5 Smac and caspase-3 get recruited to the IAP-IAP complex during apoptosis 
To check the state of the complexes in apoptotic cells, HeLa cells were treated with TNF-
CHX for 6 hours and the cytosols from the apoptotic cells isolated and analysed by gel 
filtration like before. It was seen that lower amounts of IAPs were present in the IAP-
containing fractions, suggesting that IAPs get degraded during apoptosis (Figure 10) It was 
also noticed that a small amount of cIAP-1 was now present in a fraction corresponding to 
a higher molecular weight complex around 850 kDa in size.  
During apoptosis, Smac binds to the IAPs to inactivate them. When the blots were probed 
for Smac, it was seen to be present in the fractions containing the IAP complexes.  
Further, we also found cleaved caspase-3 together with fractions containing the complexes 




recruiting and inactivating caspase-3. Smac might also bind to the complex, competing 
with the IAPs for caspase-3 binding.  
 
Fig. 10: Smac and Caspase-3 get recruited to the high molecular weight IAP complexes during 
apoptosis induction.  Gel filtration was performed on the cytosol of apoptotic HeLa cells, and the 
proteins from the fractions TCA precipitated as before. The samples from each fraction were 
probed for the presence of the IAPs, Smac and cleaved caspase-3.  
 
To confirm that it was not a cell specific response, apoptosis was induced in Jurkat cells 
with CD95 antibody and the cytosolic proteins analyzed by gel filtration as before. Smac 
and caspase-3 recruitment to the IAP complex was also seen in Jurkat cells which were 
induced to apoptosis with the CD95 Ligand. This ligand binds to specific death receptors 
on the Jurkat cells and induces apoptosis via the FAS/FASLigand pathway.  
 
 
Fig. 11: Immunoblot of gel filtration experiments with Jurkat cells induced to apoptosis. Smac and 
Caspase-3 are recruited to the IAP complexes upon apoptosis induction in Jurkat cells. Gel 
filtrations studies on apoptotic Jurkat cells (after treatment with the CD95 antibody) showing the 
IAPs, SMAC and cleaved caspase-3 in a high molecular weight complex. molecular weight 
complex.  
 
It was interesting to check if the complex would break down in the absence of any one of 




complex? A HeLa cell line expressing a permanent XIAP knock down was used and 
analyzed by gel filtration studies as before. Interestingly, it was seen that the cIAP-1 and 
cIAP-2 were no longer present in the high molecular weight complex in the absence of 
XIAP (Fig. 12). This further confirms that the IAPs interact and perhaps regulate the 
stability of one another. A part of cIAP-2 was now seen in a different fraction, around 850 
kDa in size, suggesting its presence in a different complex. 
 
 
Fig. 12: IAPs are not detected together in high molecular weight complexes in absence of XIAP. 
Gel filtration was performed on the cytosol from XIAP knock down cells, and the proteins from 
each fraction were TCA precipitated. Immunoblotting was done to check for the presence of cIAP-
1 and cIAP-2 in the different fractions. 
 
To conclude, it was observed that cIAP-1, cIAP-2 and XIAP exist in large native 
heteromeric complexes in a cell. During apoptosis induction, Smac and caspase-3 got 
recruited to these IAP complexes. The results were verified in three different cell lines. 
Further, when XIAP expression was reduced by RNAi, the presence of other members was 




2.3 BH3 only proteins are not degraded in cells infected with 
Chlamydia trachomatis  
It has been proposed that the apoptosis resistance in Chlamydia infected cells was due to 
the degradation of the BH3 only proteins in the cells. To check for the degradation of these 
proteins, an infection time course was carried out and the levels of Bim, Bad, Puma and 
Bid at the different time points were analysed by immunoblotting. It was seen that the 
levels remained more or less unchanged during the course of infection (Figure 13). 
Quantification of the bands was done by densitometric analysis and the results plotted (Fig. 
14). The results showed that the protein levels of Bid, Bad and Puma remained almost the 
same during infection time course. The levels of Bim were seen to decrease at 15 h post 
infection. However, 24 h post infection the Bim levels were seen to be similar to the 
control cells. Since Chlamydia can block apoptosis at 24 h post infection, it is unlikely that 
the slight Bim degradation (as observed at the 15 h time point) confers the resistance. The 
decrease in the Bim levels could be because of reversible phosphorylation of Bim at an 
early phase of infection.  
To check if the antibodies were specific for the protein of interest, siRNAs were used to 
silence the respective genes, and the transfected cells used as a negative control. To 
compare our infection conditions with other published conditions, the levels of cytokeratin-
8 were also determined at different time points by immunoblotting. Cytokeratin-8 is 
another protein that gets cleaved during chlamydial infection. In fact the degradation of 
cytokeratin 8 is used as a marker for the chlamydial protease like activity (proposed to be 
induced by the chlamydial protease like activity factor (CPAF)). It was seen that as 
observed in other studies, the levels of cytokeratin 8 decreased significantly with the 
growth of the chlamydial infection (seen by the levels of the chlamydial Hsp60) which 







Fig. 13: Immunoblot showing protein levels of BH3 only proteins in a time course of infection in 
HeLa cells.  HeLa cells were infected with C. trachomatis for the indicated time points. In the first 
lane of every blot, a sample with a siRNA mediated knock down of the particular BH3 only protein 
(BAD, PUMA, BIM or BID) was used as a control to check the specificity of the antibody. 
Bacterial Hsp60 (CHSP60) was used as an infection marker. The activity of chlamydial protease 
like activity factor, CPAF, was measured by detecting the levels of its substrate- Cytokeratin-8 at 
the different time points.  
 
 
Fig. 14: Densitometric analysis of immunoblots from Fig 13.  The intensity for each band was 
normalized with the respective Actin control. The intensities of bands were determined to be nearly 






To further confirm the results, HeLa cells were grown on coverslips, infected with 
C.trachomatis and fixed at different time points. The BH3 only proteins were stained with 
the respective antibodies and the levels at different time points compared by 
immunofluorescence (Figure 15). As before, antibody specificity was checked by using 
RNAi for the respective genes. Consistent with the immunoblot analysis it was seen that 
the BH3 only proteins levels remained more or less constant during the infection time 
course. 
 
These data show that the degradation of the BH3 only proteins cannot account for the 
apoptosis resistance in the infected cells. Therefore it becomes apparent that there must be 
different mechanisms at work in the cell that confer a block in apoptosis.  
 
 
Fig. 15: Levels of BH3 only proteins remain constant during the course of infection. HeLa cells 
were infected with Chlamydia trachomatis for different time points and stained for the BH3 only 




                                                
2.4 RNA interference screen to identify factors involved in infection 
induced apoptosis resistance 
An RNAi screen was designed to determine host cell genes, whose silencing led to the 
sensitizing of the cells to apoptosis. A custom made siRNA library against 473 genes was 
employed to target part of the genome related to apoptosis, cellular trafficking and cell 
signalling. The siRNAs were validated with qRT-PCR analysis to ensure a high level of 
knock down during the screening process. HeLa cells were grown on a 96 well plate. Three 
days after transfection of siRNAs to silence gene expression, cells were infected with 
Chlamydia and apoptosis was induced with TNF-/CHX at 24 h post infection. The 
analysis was carried out at least three times independently with each siRNA. The nuclei of 
the cells were stained with Hoechst stain together with the M30 staining to mark the 
apoptotic cells. An automatic microscope was used to capture images of the stained cells 
and nuclei in each well of the different 96 well plates, and the numbers counted with a 
sensitive image analysing software, ScanR. Computations were done to identify 
statistically significant results- targets whose silencing lead to a significant apoptotic 
induction in the infected cells, as compared to the control cells. 
To confirm the results from the automatic microscope and the image analysis software, the 
acquired images were analysed manually. The nuclei and the apoptotic cells in these 
samples were counted manually and compared with the results obtained by the software. 
This was required to rule out any false targets obtained from the image analysis software.  
A group of 32 targets was identified with the automated microscopy and image analysis 
and the results were confirmed manually. The targets are mentioned in Table 1. The most 
prominent target emerging from the screen was Mcl-1, a member of the Bcl-2 family 
(Figure 16). Besides Mcl-1, at least six member of the RAS signalling pathway were 
identified. Though previous reports have shown the activation of the MAPK pathways on 
Chlamydia infection, the identification of these targets clearly implicated the involvement 
of these pathways in apoptosis resistance. It should be noted that other members of the 
MAPK signalling cascade might not have been identified because the corresponding 
apoptosis levels might be lower than the threshold values followed. It is also likely that 
because of the redundant nature of pathway proteins, knock down of any one protein might 
not fully block the signalling cascades. In this scenario, the enhanced survival “signal” 
 




upon Chlamydia infection would still be transmitted downstream, and consequently the 
particular protein would fail to get identified in the screen. Pathway analysis of the targets 





Fig. 16: RNAi screen identifies Mcl-1 as a prominent factor involved in apoptosis resistance in the 
Chlamydia infected cells.  Images obtained from the automated microscope showing the siLuci 
transfected and the siMcl-1 transfected cells in the RNAi screen. The nuclei are stained blue with 
Hoescht and the apoptotic cells are stained green with the Cytokeratin stain. There is an increase in 
the apoptosis levels in the siMcl-1 cell population infected with C.trachomatis, as compared with 
the siLuci population as can be seen by the increase in the number of green cells.  
 
2.4.1  Pathway analysis of the targets from the screen implicates HIF-1 as a key 
regulator of apoptosis resistance 
The targets were further analyzed with the specialized software- Ingenuity Pathway 




the targets involved the transcription factor Hypoxia Inducible Factor-1 (HIF-1) (Figure 
17). The role of HIF-1, and its regulatory subunit HIF-1 was analyzed in detail, as 
described later. 
 
Fig. 17: Pathway analysis identifies HIF-1as atargets from the RNAi screen. The genes mentioned 
in the pathways above are Transforming Growth Factor (TGFB), Interleukin 1 
IL1Btransforming growth factor, beta receptor II (TGFBR2), Tumor Necrosis Factor (TNF), 
ADP-ribosylation factor 6 (ARF6), Protein Kinase C (serine) (Pkc (s)), rho family small GTP 
binding protein (Rac1), Hypoxia Inducible Factor 1 (HIF-1), mothers against decapentaplegic 





2.5 Mcl-1 constitutes the prominent block upstream of the 
mitochondria, to prevent apoptosis in Chlamydia infected cells 
 
Mcl-1 was identified as a major player in apoptosis resistance by the RNAi screen. We 
next wanted to see how the Mcl-1 expression is modulated during the infection and the 
effect this has on various stages of the apoptotic pathway 
2.5.1 Mcl-1 gets up regulated during chlamydial infection 
Consistent with previous reports, it was seen that the mRNA levels of Mcl-1 get up 
regulated during infection. The up-regulation was seen to occur in a time dependant 
manner corresponding to the growth of the infection in the cell (Figure 18). 
Further, immunoblot analysis showed that the protein levels of Mcl-1 were also 
significantly increased upon infection. This was also confirmed in the human primary 
END-1 cells showing that Mcl-1 up-regulation is a general effect of chlamydial infection. 
A time course of infection revealed an increase in the protein levels of the Mcl-1 after 15 
hours of infection.  
 
Fig. 18: Mcl-1 expression is up regulated during chlamydial infection. A: HeLa cells were infected 
with Chlamydia trachomatis and q-RT PCR analysis performed for the different time points of 
infection. The mRNA levels of Mcl-1 increased with the time course of infection. 
B: End1 and HeLa cells were infected with Chlamydia and lysed at different time points post 
infection. Immunoblot analysis revealed the increase in Mcl-1 at the protein level in both cell lines, 
with the infection time course. 
2.5.2 Mcl-1 is up regulated in a MAPK dependant process 
Many of the targets of the screen belonged to the MAPK signalling family. Manual 




noticeable sensitization of the infected cells to apoptosis, though the sensitization was not 
as complete as that with Mcl-1. The involvement of the MAPK pathways in the apoptosis 
resistance was expected since it has already been shown before that chlamydial infection 
can lead to the activation of MAPK in HeLa cells. Consistent with these results, it was also 
seen in our group that Ras-GTP could be pulled down from the infected cells. The 
phosphorylation of ERK, AKT and Raf was also observed after infection [159].  
But the question remained as to how exactly these pathways convey the resistance against 
apoptosis. It is known that MAPK kinase pathways can regulate Mcl-1 expression. It was 
probable that the chlamydial infection caused the activation of the MAPK signalling 
pathways resulting in the accumulation of Mcl-1 in the cells.  
To check for this, specific inhibitors for the MAPK pathways were employed and the 
levels of Mcl-1 after infection was checked. Uo126 was used to inhibit MEK-1 and 
LY294002 was used to block the PI3K pathway. The effectiveness of the inhibitors on the 
pathway was checked by probing for pAKT and pERK.  
The results showed that the Mcl-1 up-regulation was blocked at the protein level, in the 
presence of both the inhibitors (19). Different concentrations of the inhibitors were used, 
and the block was seen to be concentration dependent.  
 
 
Fig. 19: MAPK pathways are required for Mcl-1 up-regulation in the Ctr. Cells were infected with 
Chlamydia and then treated with different concentrations of the MEK-1 inhibitor UO126 or the 
PI3K inhibitor LY294002. The cells were lysed 20 h post infection and the samples were probed 
for the levels of Mcl-1, pAKT, pERK by immunoblotting. The second lane has samples from cells 
infected with heat inactivated (HI) Chlamydia. The infection mediated up-regulation of Mcl-1 was 





In additional work done in the group, it was seen with Q-PCR analysis that the Mcl-1 up-
regulation at the mRNA level was dependent on the MEK pathway, whereas PI3K pathway 
was required for the protein stability of Mcl-1 in infected cells [159]. Interestingly, it was 
seen that the inhibitors also blocked the up-regulation of cIAP-2 at the protein level. (The 
levels of cIAP-2 remained unaltered at the mRNA level).   
 
2.5.3 Mcl-1 is required for resistance to apoptosis in the infected cells 
HeLa cells with a permanent Mcl-1 knock down were sensitized to apoptosis when treated 
with TNF- after infection. Apoptosis was induced at different time points of infection, 
and it was seen that after 24 h post infection, the shMcl cell line had near complete PARP 
cleavage whereas the control cell line had a block in PARP cleavage (Figure 20). The 
shMcl cell line was the clone-1 as characterized in Figure 21. 
Interestingly, after 48 h the cells were resistant to apoptosis even in absence of Mcl-1, 
confirming that there is a different mechanism at play at the later stages of infection. 
 
 
Fig. 20: Silencing of Mcl-1 sensitizes cells to apoptosis during early time points of infection. 
Control (HeLa cells with empty vector) and shMcl-1 cells were infected and treated with TNF-
/CHX at the different indicated time points of infection. PARP was probed with immunoblotting 
to measure apoptosis. Bacterial Hsp60 (CHSP60) was used as an infection marker, while Tubulin 
was used as a loading control. Knock down of Mcl-1 sensitized cells to apoptosis 24 h post 
infection. However, the cells continued to block apoptosis at 48 h post infection, even in the 






Fig. 21: HeLa cell lines containing vectors for shRNA against Mcl-1 or empty vector (pLVTHM). 
The vector system imparts a inducible knock down on the cells, upon treatment with Doxycycline 
(DOX). However, the 2 cell lines were observed to have a significant knock down of Mcl-1 even 
without DOX treatment, and were used as such in subsequent experiments. 
 
2.5.4 The inhibition of PI3 Kinase sensitized infected cells to Staurosporine 
induced apoptosis. 
The primary human cell line END-1 was sensitized to apoptosis after treatment with 
LY294002 to reduce the Mcl-1 levels in the cells post infection. The END-1 cells were 
indifferent to siRNA transfection and therefore the PI3K inhibitor was employed to block 
Mcl-1 up-regulation post infection. Similar to the earlier results, it was observed that a 
block in the PI3Kinase led to decrease in the Mcl-1 levels during infection. The infected 
cells were moreover readily susceptible to apoptosis with staurosporine after treatment 
with the inhibitor (Figure 22). 
  
 
Fig. 22: Inhibition of PI3K sensitizes infected cells to apoptosis, by blocking the up-regulation of 
Mcl-1. END1 cells were treated with LY294002, 1 hour post infection with Chlamydia. Apoptosis 
was induced with Staurosporine and immunoblotting done to measure the levels of apoptosis by 




check for the inhibitor function, while chlamydial HSP60 levels were probed as an infection 
marker. As before, Bacterial Hsp60 (CHSP60) was used as an infection marker. END1 cells 
infected with Chlamydia had depleted Mcl-1 levels and were prone to apoptosis induced by 
staurosporine after treatment with a PI3K inhibitor. which. 
 
2.5.5  Mcl-1 is required for the block in mitochondrial outer membrane 
permeabilization in the infected cells, upon apoptosis induction 
Silencing of Mcl-1 led to the release of SMAC/DIABLO from the mitochondria upon 
apoptosis induction with TNF-CHX. Control and shMcl-1 cells were infected and treated 
with TNF-CHX. The cells were stained for SMAC and its release from mitochondria 
observed in the form of decrease in the punctuated staining in the cytosol. SMAC gets 
degraded in the cytosol upon release from the mitochondria, and this can be seen as a 
decrease in the SMAC release (Figure 23and 24).  
The results were quantified by manually counting the number of cells with SMAC release 
and a graph plotted (Figure 25) It was calculated that the release of SMAC in the shMcl-1 






Fig. 23: A: Release of Smac from mitochondria upon apoptosis is blocked in infected cells. HeLa 
cells infected with Chlamydia (Ctr) and treated with TNF-CHX (TNF). Immunofluorescence 
analysis was done with Smac stained in green and nuclei stained blue. In healthy cells, Smac has a 
mitochondrial localisation, while in the apoptotic cells, Smac gets released into the cytosol where it 




The red arrows mark such cells. The inclusions in the infected cells have been marked with black 
arrows. 
 
Fig. 24: Release of Smac from mitochondria upon apoptosis is rescued in infected cells in absence 
of Mcl-1. shMCl-1 cells infected with Chlamydia (Ctr) and treated with TNF-CHX. 




before. The red arrows mark such cells. The inclusions in the infected cells have been marked with 
black arrows. 
 
Fig. 25: Quantification of Smac release in the experiment from Figure 24 The total numbers of 
cells, and cells with loss of Smac staining were counted manually and the percetange calculated. –
VE refers to uninfected cells. It was observed that there is an increase from 10 % to 40 % in the 
number of infected cells with Smac release upon apoptosis induction, after the knock down of Mcl-
1. 
2.5.6  Loss of Mcl-1 can rescue release of cytochrome c in the infected cells upon 
apoptosis induction 
During the course of apoptosis induction in a cell by the mitochondrial pathway, 
cytochrome c gets released into the cytosol irreversibly commiting the cell to death. It has 
been shown that cell death occurs immediately (within minutes) following the release of 
cytochrome c. As a result, it is difficult to observe cytochrome c in the cytosol by 
immunostaining, because of the short time period between the cytochrome c release and 
the subsequent apoptosis of the cell. Moreover, the time point of release of cytochrome c 
differs slightly for the cells in a population, and therefore at any chosen time point (when 
the cells are fixed for microscopy) there would be only a few cells with cytochrome c 
localised in the cytosol, with a majority of cells either already rounded up or intact with no 




Therefore, to monitor the release of cytochrome c, a HeLa cell line expressing a GFP-
Cytochrome c construct was used and time lapse microscopy done. Infected and non-
infected cells were treated with TNF-CHX and time lapse confocal microscopy used for 
detection of cytochrome c. The PI3K inhibitor LY294002 was used to obtain lower levels 
of Mcl-1 in the infected cells. As expected, it was seen that Chlamydia infected cells had 
no release of cytochrome c upon treatment with TNF-CHX. However, in the presence of 
LY294002, and subsequent reduction in the Mcl-1 levels, the release of cytochrome c 
occurred as normal. Once again it was observed that only the cells carrying a small 
inclusion were sensitized to apoptosis. The cells carrying larger inclusions had no release 
of cytochrome c.  
 
 
Fig. 26: Cytochrome c is  localized in the mitochondria of resting cells. Image from time lapse 






Fig. 27: Cytochrome c is released from the mitochondria on apoptosis induction. Images from time 




CHX treatment is marked in red. At the 3:15 h time point the cell inside the marked field shows a 
release of cytochrome c. At the next time point, the cell is seen to be rounded up with advanced 

















2.5.7  Loss of Mcl-1 leads to caspase-9 activation in the infected cells, upon 
apoptosis induction 
Mcl-1 knock down and control cells were treated with TNF-c and Staurosporine with and 
without infection. Processing of caspase-9 and the extent of apoptosis induction was 
determined by immunoblotting. Caspase-9 cleavage was abrogated in the infected control 
cells. However, in the shMcl-1 cell lines, cleaved caspase-9 fragments were observed. It 
should be noted that although cleavage of caspase-9 is not a marker of its activation, the 
cleavage is a probable intermediatary step of apoptosis, which is absent in the Chlamydia 
infected cells. Loss of Mcl-1 leads to the cleavage of caspase-9 and the subsequent cell 
death by apoptosis, as judged by the PARP cleavage in the Figure 30  
 
Fig. 30: Caspase-9 processing and subsequent apoptosis occurs in infected cells in absence of Mcl-
1.  Control and shMcl-1 cells were infected and treated with TNF-CHX or Staurosporine (STS). 
The samples were probed for PARP and caspase-9 levels by immunoblotting. In the Staurosporine 
treated samples, cleavage of caspase-9 is detected by the loss of the caspase-9 proform.  In the 
control cells, caspase-9 processing was blocked, but in the absence of Mcl-1 the caspase-9 
processing occurred as normal upon apoptosis induction by TNF-/CHX or staurosporine. 
 
 
Thus in the absence of Mcl-1 there is mitochondrial permeabilization followed by Smac 
and cytochrome c release and the consequent caspase-9 and caspase-3 activation. This 
indicates that Mcl-1 is the most important factor constituting the block in the apoptosis 





2.6 HIF-1 gets stabilized and modulates the expression of anti-
apoptotic proteins during C. trachomatis infection 
As described before, HIF-1 had been identified as a regulator involved in the different 
pathways likely to be involved in apoptosis resistance in the infected cells. We therefore 
analyzed the state of Hypoxia Inducible Factor-1 (HIF-1) during infections. As described 
in the introduction, HIF-1 is composed of HIF-1and HIF-1 subunits. While HIF-1 is 
constitutively expressed in cells, HIF-1 is regulated by the oxygen levels in the cells.  
Under normoxic conditions, HIF-1 gets degraded in the cytoplasm of the cells, whereas 
in hypoxic conditions it gets stabilized and accumulates in the cell. As such HIF-1 is 
present at very low levels in healthy cells.  
2.6.1  HIF-1 gets stabilized at the protein level during early infection, but gets 
degraded during late time points of infection 
We checked for the levels of HIF-1 during infection with C.trachomatis. At first it was 
seen that 24 hours post infection, there was no increase in the levels of HIF-1. However, 
a time course of infection revealed that HIF-1 is first up regulated and then degraded 
during the infection.  
As seen in Figure 31,  the levels of HIF-1 are increased around 12 hours of infection. The 
stabilization required active growth of the bacteria, as there was no increase in HIF-1 
levels when cells were treated with heat inactivated Chlamydia. CoCl2 was used to 
simulate hypoxia in cells leading to detectable levels of HIF-1, as a positive control.  
The lower figure shows the degradation of HIF-1 24 hours post infection. Interestingly, 
treatment of the infected cells with the MEK-1 inhibitor UO126 blocked the degradation, 
suggesting a role of the ERK pathway in infection induced modulation of HIF-1 - either 
the bacterial growth is affected in such a way as to block hypoxic conditions in the cells, or 







Fig. 31: HIF-1 expression is up-regulated in cells during early time points of Ctr. Infection. A: 
HeLa cells were infected with heat inactivated Chlamydia (HI) or Chlamydia and lysed after 12h. 
The samples were probed for the levels of HIF-1 by immunoblotting. The last lane shows a 
positive control of cells treated with CoCl2 for 4 h. CoCl2 simulates hypoxia in the cells leading to a 
strong up-regulation of HIF-1.  
B: Cells were infected with (active and heat inactivated) Chlamydia for 24 h and probed for Hif-1 
as before. Cells were infected with or without the MAPK inhibitors UO126 (10 μM) and 
LY294002 (60 μM).  HI referes to Heat Inactivated Chlamydia. HIF-1 was strongly degraded 24 
h post infection, but this degradation was blocked in the presence of U0126. 
 
2.6.2  HIF1- is not transcriptionally regulated during infection 
The accumulation of HIF-1 is not due to increased expression at mRNA level, but due to 
stabilization at the protein level. When an infection time course was performed it was seen 
that the mRNA levels of HIF-1 remained more or less constant through the course of the 
infection. In contrast, Mcl-1 was up regulated as described before. 
This confirms that the accumulation of HIF-1 in the cells is due to stabilization in the 








Fig. 32: HIF-1 is not transcriptionally regulated during chlamydial infection.  HeLa cells were 
infected for the indicated time points with or without the presence of MAPK inhibitors – 10μM 
UO126 or 60μM LY294002.  The expression of Mcl-1 and HIF-1 was analysed by q-RT PCR. As 
stated before, Mcl-1 gets up-regulated 20 hours post infection and inhibition of MEK-1 with 
LY294002 reverses this effect. On the other hand, HIF-1is not regulated by the infection at the 
mRNA level. 
2.6.3 HIF-1  gets translocated to the nucleus during infection 
For achieving the proper functionality of the Hypoxia Inducible Factor, HIF-1 needs to 
be translocated to the nucleus, where it binds to HIF-1to form the transcriptionally active 
HIF-1 complex. We therefore carried out immunofluorescence studies to look for the 
localisation of HIF-1 during the infection time course. In the absence of infection, it was 
seen that HIF-1 was localized to the cytosol. However after 12 hours of infection, HIF-1 
expression levels were slightly increased and a nuclear localisation was also seen. As seen 
before in the immunoblot studies, HIF-1 was seen to get degraded around 24 hours of 






Fig. 33: HIF-1 translocates to the nucleus 12h post Ctr. Infection. HeLa cells were infected with 
Chlamydia and fixed at the different indicated time points. The cells were stained for Hif-1in 
green (upper row), and the nuclei were stained blue with hoescht. Hif-1 has a cytoplasmic 
localization in healthy cells. 12 hours post infection, cells with Hif-1 translocated to the nucleus 
can be observed (marked with arrows). After 16h of infection, there is a marked decrease in the 
Hif-1 levels in the cells. 
2.6.4  Hypoxia Inducible Factor is required for the transcriptional up-regulation 
of Mcl-1 after infection with C.trachomatis 
HIF-1 has been shown to be a transcription factor responsible for regulating Mcl-1 [112].  
We therefore checked for the mRNA levels of Mcl-1 in the absence of HIF-1 after 
chlamydial infection. In the control cells transfected with an siRNA against Luciferase 
(siLuci) Mcl-1 was up regulated in response to the infection as observed before. However, 
after HIF-1 knock down, the mRNA levels of Mcl-1 did not increase like in the control 
cells. The result was statistically significant, with a p-value ≤ 0.01. This proved that Mcl-1 







Fig. 34: Mcl-1 up-regulation is blocked at the mRNA level in absence of HIF-1 in the Ctr. 
infected cells. HeLa cells were transfected with siRNA against Luci, Hif-1 or Mcl-1 and infected 
with Chlamydia for 24 hours. The expression levels of Hif-1 and Mcl-1 mRNA were analyzed by 
q PCR. “–“ refers to uninfected samples. Mcl-1 levels were increased as expected, in the control 
(siLuci) after chlamydial infection. However, after knock down of Hif-1, the chlamydial infection 
failed to up-regulate the levels of Mcl-1. 
2.6.5  Loss of HIF-1 sensitizes Chlamydia infected cells to apoptosis 
siRNA against HIF-1, Mcl-1 and Allstar were used to transfect cells, and then the cells 
were infected and treated with TNF-CHX as before (Figure 35). Knock down of Mcl-1 
had a strong sensitizing effect on the infected cells. However, knock down of HIF-1 had a 
weak sensitizing effect as seen in the PARP cleavage in the figure. The phase contrast 
pictures of the apoptotic cells also show the same observation. The low sensitizing effect 








Fig. 35: Loss of HIF-1 sensitizes Chlamydia infected cells to apoptosis. Cells were transfected 
with siRNAs against Allstar, Hif-1 or Mcl-1 and infected with Chlamydia after 48 hours. 
Apotosis was induced with TNF-/CHX after 24 h post infection and the PARP cleavage measured 
by immunoblotting. Bacterial Hsp60 (CHSP60) was used as an apoptosis marker. HeLa cells 




Fig. 36: Phase contrast images of cells from the experiment in Figure 35. The knock down of Hif-







Table 1 List of high confidence hits identified by RNAi screen which sensitize infected 
cells for TNF-/CHX induced apoptosis. 



















ras-related C3 botulinum toxin substrate 1 (rho 
family, small GTP binding protein Rac1) 
RAS family member, 
induces cytoskeletal 
changes 








mitogen-activated protein kinase 14 Stress activated protein 
kinase  









NLR family, pyrin domain containing 5 Inflammatory response, 
innate immunity 






11 VDAC2 voltage-dependent anion channel 2 Role in cell death; 
inhibitor of BAK 
12 MCl-1 
 
myeloid cell leukemia sequence 1 Anti-apoptotic Bcl-2 
family member 












met proto-oncogene (hepatocyte growth factor 
receptor) 




TNF receptor-associated factor 6 Adaptor protein – 
involved in NF-kappaB 
activation 
















KRIT1, ankyrin repeat containing Plays role in integrin 
mediated 
adhesion/migration 





Mediterranean fever Inflammatory response 
22 RBBP4 
 
retinoblastoma binding protein 4 Modulates E2Fs 
23 EIF5A 
 




nucleosome assembly protein 1-like 1 mitotic regulation 
25 SKP1A 
 
S-phase kinase-associated protein 1A (p19A) Cell cycle regulation 
 Other hits 
 
  






27 BIRC4 baculoviral IAP repeat-containing 3 Positive control, major 
caspase inhibitor, anti 
apoptotic 
28 SLC3A2 solute carrier family 3 (activators of dibasic and 
neutral amino acid transport), member 2 
Amino acid transport; 
Calcium homeostasis 
29 CLTA clathrin, light chain (Lca) Structural component of 
endocytic vesicles 
30 PAGE5 P antigen family, member 5 (prostate associated) Not known 
31 IK IK cytokine, down-regulator of HLA II Immune response 
32 PABPC4 poly(A) binding protein, cytoplasmic 4 (inducible 
form) 
stability of labile mRNA 
33 NOS1 nitric oxide synthase 1 (neuronal) NO generation 







                                                
3  Discussion 
 
Inhibition of apoptosis constitutes an important immune escape mechanism for certain 
bacteria, helping them to stay inside the host cell for longer periods of time. Chlamydia 
spp. can robustly block the mitochondrial pathway of apoptosis, thus protecting infected 
host cells against various stimuli.  
In the present study, it was seen that the chlamydial infection could block the apoptotic 
pathway at multiple levels by modulation of specific host cell factors. Most prominent 
among these were the anti-apoptotic proteins Mcl-1 and cIAP-2 which were found to be up 
regulated during the chlamydial infection, and were seen to be absolutely required for 
apoptosis inhibition. 
Although cIAP-2 was the only member of the IAP family that was up regulated, it was 
seen that the presence of cIAP-1 and XIAP was also needed to block apoptosis in the 
infected cell. That these IAPs work together in a concerted mechanism was further 
confirmed when it was observed that cIAP-1, cIAP-2 and XIAP exist in large native 
heteromeric complexes in a cell. When XIAP expression was reduced by RNAi, the 
presence of other members in the large complex was not detected by the gel filtration 
technique employed.  
Previous reports have shown that the MAPK pathways get activated early during the 
chlamydial infections [164]. Consistent with these reports, Ras-GTP could be pulled down 
and ERK and AKT phosphorylation could be observed after the infection. It was observed 
that not only were the MAPK pathways activated during the infection, but these were also 
required for the apoptosis inhibition. A high throughput RNAi screen to identify host 
factors required for the apoptosis resistance, confirmed that the MAPK pathways were 
critically involved2. Six factors associated with the RAS signaling machinery were found 
to be required for conferring apoptosis resistance. Other factors identified included Mcl-1, 
the tyrosine receptor kinase (c-Met) as well as some mitochondrial, nuclear and 
cytoskeletal proteins.  
Analysis of the MAPK pathways revealed that these pathways confer apoptosis resistance 
in the infected cells, by regulating the expression of both Mcl-1 and cIAP-2. The infection 
led to an increase in expression of both Mcl-1 and cIAP-2, which was reversed in the 
 




presence of the MEK-1 inhibitor UO126 or the PI3K inhibitor LY294002. The 
Raf/MEK/ERK pathway was required for the transcriptional up-regulation of Mcl-1. The 
PI3K/AKT pathway was important for the stabilization of the Mcl-1 and cIAP-2 protein 
level. 
Detailed pathway analysis of the factors identified from the screen revealed HIF-1 as a 
key player involved in the differential expression of the survival genes during infection. 
Consistent with this, it was found that HIF-1 does get stabilized and accumulates in the 
cell during an early time point of infection. This fits well with earlier reports showing that 
the p44/42 MAPK is critically required for the increased expression of HIF-1 induced by 
bacterial lipopolysaccharide [165]. Rupp et. al. have shown that Chlamydia pneumoniae 
regulates the HIF-1 stabilization in human host cells [124]. Here we observed that 
Chlamydia trachomatis infection similarly regulates HIF-1 levels in the cell, and 
moreover, this plays a key role in apoptosis inhibition.  
As shown previously, the transcription factor, HIF-1, regulates the expression of various 
survival genes, including cIAP-2 and Mcl-1 [112,116]. Consistent with this, both Mcl-1 
and cIAP-2 are transcriptionally up-regulated after the chlamydial infection. The 
involvement of HIF-1 in the chlamydial induced apoptosis resistance was confirmed by 
silencing of HIF-1 that blocked the over-expression of Mcl-1 at the mRNA level, in the 
infected cells.   
 
3.1 Requirement of bacterial and host cell protein synthesis for 
apoptosis inhibition  
The ability of Chlamydia spp. to block host cell apoptosis has long been known. Early 
reports suggested that chlamydial protein synthesis is essential for the resistance since 
treating the cells with the prokaryotic transcription inhibitor rifampin or the translation 
inhibitor chloramphenicol abrogated apoptosis inhibition. It was also reported that since 
Chlamydia could block apoptosis even in the presence of the eukaryotic translation 
inhibitor cycloheximide, host cell synthesis was not required for apoptosis inhibition [148]. 
However, it was observed that a block in up-regulation of host proteins like Mcl-1 or IAPs 
could sensitize cells to apoptosis, which shows that host protein production is required by 
Chlamydia for imparting resistance. In fact, around 32 host cell factors were identified that 




                                                
discrepancy about the involvement of host cell protein synthesis could be because of the 
inability of cycloheximide in inhibiting translation completely. In fact even during the 
presence of high concentration of cycloheximide, proteins, among others (Mcl-1), were 
observed to be overexpressed during infection. 
 
3.2 Block of mitochondrial outer membrane permeabilization during 
infection 
It has been shown that the chlamydial infected cells failed to achieve the activation of Bax 
and Bak, and consequently mitochondrial permeabilization is not achieved [149,150]. 
Reports have also shown that infection fails to impart resistance in type 1 cells, which do 
not require the mitochondrial pathway for activation of the effector caspases [151]. It 
becomes clear that Chlamydia confers a block at the mitochondrial level which explains 
the resistance to apoptosis initiated through different pathways that collude at the 
mitochondria. 
3.2.1 BH3 only proteins are not degraded during Chlamydia trachomatis 
infection 
Previous reports attributed the block in mitochondrial permeabilization during the 
chlamydial infection to a broad scale degradation of the different BH3-only proteins in the 
cell [150,152,153,154]. The Chlamydial protease-like activity factor (CPAF) was shown to 
be responsible for targeting those active proteins with an exposed BH3 domain, for 
degradation, implying that Chlamydia destroy most, if not all, active BH3-only proteins. In 
absence of the BH3-only proteins, death signals cannot be transmitted to the mitochondria, 
and this could account for the block in apoptosis upstream of the mitochondria. To verify 
this, the levels of the different BH3 only proteins were extensively analyzed in an infection 
time course experiment. Immunoblot as well as immunofluorescence studies with validated 
antisera showed that there was no major change in the levels of these proteins after 
infection. To rule out differences in infection conditions, the activity of CPAF during the 
infection was checked by measuring the levels of its substrate - Keratin 8. CPAF has been 
reported to be a protease secreted by Chlamydia that is both necessary and sufficient to 
cleave Keratin 8 to modify the host cell cytoskeleton [166]. It is probable that the 
 




contradictory results observed here could be because of differences in experimental 
conditions including different cell types, Chlamydia serovars etc.   
In an elegant experiment to analyze the extent of apoptosis inhibition in the infected cells, 
it was noticed that the cytosolic extract from chlamydial infected cells resisted the 
activation of caspase-3 even upon treatment with cytochrome c [155]. This suggests a 
block in the apoptotic pathway downstream of the mitochondria. The BH3 only proteins 
can regulate the mitochondrial outer membrane permeabilization. Degradation of the BH3 
only proteins, would not account for this block in caspase-3 activation after cytochrome c 
treatment. It becomes clear that the degradation of the BH3-only proteins is not the only 
mechanism employed by Chlamydia to achieve the strong and widespread inhibition to 
apoptosis induced by various stimuli.  
3.2.2 Up-regulation of Mcl-1 is responsible for inhibiting mitochondrial outer 
membrane permeabilization during C. trachomatis infection 
In the present study, the over-expression of Mcl-1 during infection was seen to cause the 
block in the apoptotic pathway upstream of the mitochondria. There was a time dependent 
increase in the mRNA and protein levels of Mcl-1. In the absence of Mcl-1, the infected 
cells showed mitochondrial outer membrane permeabilization, Smac and cytochrome c 
release, caspase-9 and caspase-3 activation and finally cell death upon treatment with 
apoptosis inducers. Silencing of Mcl-1 with RNAi or its down-regulation by inhibiting the 
MAPK pathways sensitized infected cells to apoptosis.  
Smac gets degraded in the cytosol upon release from the mitochondria during apoptosis 
[167]. As such, Smac release from the mitochondria was detected by its loss of staining in 
immunofluorescence studies. However, detecting the release of cytochrome c was more 
difficult, because of the small window of time between its release into the cytosol, and the 
rounding up of cell for apoptosis. Once a cell “rounds up” due to apoptosis, it is difficult to 
see in the immunofluorescence images, if the cytochrome c is localized in the mitochondria 
or the cytoplasm. Therefore, time-lapse microscopy was employed using a HeLa cell line 
expressing GFP-cytochrome c and thus the the translocation of cytochrome c to the cytosol 
was detected. 
To check for the role of Mcl-1 in the release of cytochrome c in the infected cells, the PI3K 
inhibitor, LY294002, was employed to deplete Mcl-1 levels. As observed before, blocking 
PI3K/AKT pathway with, LY294002 could inhibit the up-regulation of Mcl-1 in the 




infected cells, in the presence of the inhibitor, confirming the role of PI3K/AKT pathway 
in blocking the mitochondrial membrane permeabilization through Mcl-1. 
Recently, the role of Mcl-1 in sustaining bacterial infection has also been shown for 
Helicobacter pylori infections in the gut epithelia. It was observed that H.pylori infection 
could suppress the apoptosis initiated by the host defence mechanisms in the infected cells. 
The infected cells had increased levels of activated-ERK and Mcl-1 which were required 
for apoptosis inhibition [168]. Similarly, Salmonella enterica serovar Typhimurium 
inhibits camptothecin-induced apoptosis in HeLa and rat small intestine epithelial cells by 
activating the PI3K/Akt pathway [169]. Anaplasma phagocytophilum prevents apoptosis in 
neutrophils by activation of p38 MAPK [170].  
It appears that the activation of MAPK pathways for the up-regulation of Mcl-1 could be a 
more common strategy for resisting host apoptotic pathways during bacterial infection.  
 
3.3 Block in caspase-3 activation during infection 
Chlamydia also block the apoptotic pathway downstream of the mitochondria, at the 
caspase-3 level. Analysis of cleaved caspase-3 immunoblots from the infected cells 
showed that with the growth of the inclusion, there is a block in the autocatalytic 
conversion of the cleaved caspase-3 p19 fragment into the p17 fragment. This incomplete 
processing of caspase-3 is similar to that seen after apoptosis induction in cells with a 
Smac knock down [171]. The block in caspase-3 processing could therefore be because of 
a block in mitochondrial permeabilization and/or because of the IAPs which directly bind 
and inhibit caspase activation.  
The Inhibitor of Apoptosis Proteins, IAPs, are important regulators of apoptosis that bind 
directly to caspase-3 and caspase-9 with their BIR domains, and thus block their activation. 
During the infection, cIAP-2 gets up regulated at the protein levels, while the levels of 
cIAP-1 and XIAP remained unaltered. The increase at protein level was detected after 
around 16 hours of infection which concurs with the time post infection of apoptosis 
resistance in the infected cell. Immunoblot analysis for cleaved caspase-3 showed that in 
the absence of cIAP-2, the block in caspase-3 processing was attenuated.  
Recently, some reports have raised doubts over the ability of cIAP-2 and cIAP-1 in directly 
inhibiting the catalytic activity of caspases [172]. However, these data clearly show that in 




                                                
effect is abrogated when cIAP-2 levels were reduced by RNAi. It should be noted that the 
role of increased expression of cIAP-2 in inhibiting apoptosis has since been confirmed 
elsewhere. When mouse macrophages were treated with LPS, there was an up-regulation 
of cIAP-2 which provided resistance to Fas induced apoptosis in the cell. Moreover, when 
the macrophages from cIAP-2 knock-out mice were treated with LPS, there was 
widespread apoptosis confirming the requirement of cIAP-2 in the apoptosis resistance 
[173]. 
3.3.1 IAPs exist in the form of native heteromeric complexes  
The presence of cIAP-1 and XIAP was important together with the high levels of cIAP-2 
to block apoptosis. Apparently, these IAPs might be working in a concerted manner, as 
part of a functional complex that blocks caspase activation. To check for this, gel filtration 
studies were done with the cytosolic extracts from HeLa cells. cIAP-1, cIAP-2 and XIAP 
were indeed detected in high molecular weight fractions of around 400 kDa. Survivin was 
not detected in the IAP-containing high molecular weight fractions. 
The presence of IAPs in a complex has been shown before. Dohi et al. reported that XIAP 
and survivin form a heteromeric complex in response to cell death simulation in vivo [174]. 
Silke et al. observed a direct interaction of XIAP with overexpressed cIAP-1 via their 
RING domains [175]. In the present work, although XIAP, cIAP-1 and cIAP-2 interaction 
was detected, survivin was not observed to be associated with the IAP complex even 
during apoptosis induction. Interestingly, loss of survivin also did not influence the 
resistance to apoptosis in Chlamydia infected cells. In contrast, XIAP which was required 
for the apoptosis resistance was crucial for the stability of the IAP complex.  In the absence 
of XIAP in the XIAP knock down cell lines, the complex seemed to break down- cIAP-1 
and cIAP-2 were no longer found in the 400 kDa fraction, but mostly in the monomeric 
fraction. cIAP-2 was also detected in a 1 MDa fraction, suggesting its recruitment to a 
different complex under these conditions. Further immunoblot studies revealed that 
depletion of XIAP affects the stability of cIAP-2 in the infected cells – cIAP-2 levels are 
not increased in the absence of XIAP upon infection. The presence of XIAP is thus vital 
for the recruitment of cIAP-1 and cIAP-2 to the 400 kDa complex which in turn might be 







                                                
To check what happens to the complex during apoptosis, gel filtration studies were 
performed on HeLa and Jurkat cells induced to apoptosis. The complex was seen to get 
disrupted, and only a low amount of IAPs was detected in the fractions. Interestingly, 
cIAP-1 was detected in a different fraction, around 850 kDa in size, in the apoptotic cells. 
During apoptosis, Smac is known to bind to IAPs to inactivate them. To check for the 
interaction of Smac to the IAP-IAP complexes, the high molecular-weight fractions from 
the gel filtration were probed with immunoblotting. Smac was found to occur in all the 
high molecular weight fractions containing the IAPs, but not in the fractions containing the 
monomeric IAPs. Smac could thus be interacting with the functional IAP complex, 
inhibiting it during apoptosis. Further, we also detected caspase-3 together with Smac and 
the IAPs in the high molecular weight fractions from the apoptotic cells. These results 
suggest that the heteromeric IAP complex might be the functional IAP unit, rather than the 
individual monomers. However, further work is required to confirm this. It would be 
interesting to isolate the IAP complexes, and analyze their inhibitory effect on caspase-3 
activity. 
The above results on IAP interactions and their disruption during apoptosis were confirmed 
with immunoprecipitation studies. Similar to what was observed in the gel filtration 
studies, endogenous cIAP-1, cIAP-2 and XIAP co-precipitated with each other. Moreover, 
active caspase-3 was seen to co-precipitate with the IAPs upon apoptosis induction.  
To conclude, the IAPs are present in large heteromeric functional complexes, where they 
work in a concerted manner to block the caspase activation. During chlamydial infection, 
cIAP-2 expression is increased, which strongly blocks caspase-3 processing. However, the 
presence of XIAP and cIAP-1, but not survivin, is important for cIAP-2 stability and 
apoptosis resistance in the infected cell. 
 
How does the loss of Mcl-1 sensitize the infected cells to apoptosis, in spite of the up-
regulation of cIAP-2? In the infected cells, increased amounts of cIAP-2 together with 
cIAP-1 and XIAP, strongly bind to active caspase-3. The block in the mitochondrial 
membrane permeabilization due to Mcl-1, leads to a reduced amount of Smac released into 
the cytosol upon apoptosis induction. This amount of Smac is evidently not enough to 
reverse the IAP-Caspase-3 interaction for apoptosis induction. However, in the absence of 
 




Mcl-1, there is increased release of the IAP-antagonist Smac from the mitochondria 
leading to apoptosis induction by complete activation of caspase-3. 
 
3.4 Modulation of the transcription factor HIF-1 to regulate survival 
genes 
The transcription factor HIF-1 consists of two subunits- the constitutively active HIF-
1present in the nucleus and the hypoxia regulated HIF-1 present in the cytosol. During 
normoxic conditions, HIF-1 gets degraded, but upon hypoxia, it gets stabilized and 
translocates to the nucleus where it binds to HIF-1to form the active HIF-1 
. 
It was observed that HIF-1 was accumulated in the cytosol of infected cells during early 
time points of infection- around 12 hours. Quantitative Real Time PCR analysis revealed 
that the HIF-1 up-regulation did not occur at the mRNA level, suggesting that its 
accumulation is due to infection induced stabilization at the protein level. It is likely that 
the hypoxic conditions arising due to the onset of infection lead to HIF-1 stabilization. At 
later time points of infection, a broad scale degradation of HIF-1 was noticed. The initial 
accumulation and later degradation of HIF-1 correlates with previous reports on 
modulation of HIF-1during Chlamydia pneumonia infection. Rupp et. al. showed that 
during early phase of C.pneumoniae infection there is stabilization of HIF-1 resulting in 
enhanced glucose uptake in the cells which would promote survival in the hypoxic 
conditions. However, during the late phase of infection, HIF-1 was targeted by the 
chlamydial protease-like activity factor (CPAF) secreted in the cytoplasm of the infected 
cells [124,124].  
In the present work, immunofluorescence studies revealed a localization of HIF-1 in the 
nucleus of the infected cells. This event precedes the formation of HIF-1, which can 
consequently lead to increased expression of the anti-apoptotic Mcl-1 and cIAP-2 
[112,116].    
To check for the role of HIF-1 in apoptosis inhibition, RNAi mediated knock down was 
carried out. However, it was difficult to obtain a high level of knock down with the 
designed siRNAs. Consequently, only a slight increase in the apoptosis levels was 




HIF-1 is a transcription factor which could lead to increased Mcl-1 and other survival 
genes expression, even when present in low amounts. Therefore, to analyze its role in 
apoptosis inhibition, a knock out cell line would be preferable. 
Nevertheless, the effect of the knock down on the mRNA expression levels of Mcl-1 was 
measured with qRT-PCR. In a significant observation, depletion of HIF-1 abrogated the 
up-regulation of Mcl-1 mRNA upon infection.  
To conclude, chlamydial infection leads to stabilization of HIF-1 and its translocation to 
the nucleus. It is possible that the infection leads to hypoxia in the cells, which would lead 
to the accumulation of HIF-1. Silencing of hif-1 gene reduced the Mcl-1 expression 
which increased the rate of apoptosis in the infected cells, though by only a small amount 
owing to the low levels of knock down.  
Previous reports have shown that severe hypoxia can promote apoptosis whereas mild 
hypoxic conditions (oxygen levels above 0.5 %) leads to its inhibition [118,119,120]. Dong 
et. al. have shown that cells under hypoxia undergo an induction of cIAP-2 [116]. 
Interestingly, they could see that the hypoxic cells were resistant to apoptosis induced by 
staurosporine, and this effect was dependent on cIAP-2 levels. It was also seen that the 
cytosol of the hypoxic cells were resistant to cytochrome c induced caspase-3 activation, 
supporting the evidence for an IAP induced block. Immunodepletion of cIAP-2 in the 
hypoxic cytosol reversed the block in caspase-3 activation upon cytochrome c treatment 
[122]. However, in the same study a mitochondrial membrane accumulation of Bax was 
reported to be suppressed on apoptosis induction. This block cannot be explained by the 
increased levels of cIAP-2 alone. It is likely that the inhibition of Bax accumulation was 
due to Mcl-1, which is also regulated by HIF-1 during hypoxia. Indeed, it has been 
shown elsewhere that HIF-1 dependent Mcl-1 expression is required for the anti-
apoptotic effect of hypoxia [112].  
These results confer accurately with the results showing that the HIF-1 dependant up-
regulation of Mcl-1 and cIAP-2 can protect cells against apoptosis. Rupp et. al. have 
shown that Chlamydia pneumoniae can stabilize HIF-1 to regulate host cell glucose 
uptake during early infection [124]. The work from the present study shows that HIF-1 





3.5 Different mechanism of apoptosis inhibition at later time points 
TNF-/CHX treatment at different time points of infection in Mcl-1 knock down cells 
showed that although the cells were sensitized to apoptosis after around 24 h post 
infection, they still resisted death after 48 h of infection. A closer look revealed that the 
size of the inclusion in the cell was crucial- cells carrying very large inclusions failed to get 
sensitized in Mcl-1 knock down cells, or after treatment with inhibitors. In fact, even the 
knock down of IAPs fails to sensitize such cells. This shows that there must be different 
mechanisms at play at later time points of infection, where the bacteria might directly 
interfere with the host apoptotic machinery.  
 
 
Fig. 37: Chlamydia trachomatis blocks apoptosis machinery of the host cell at different levels. 
During the early phase of infection, the transcription factor HIF-1gets activated leading to the up-
regulation of prominent anti-apoptotic proteins Mcl-1 and cIAP-2. It is observed that the over-
espression of these proteins is dependant on the activation of MAPK pathways during the infection. 
Mcl-1 confers an active block in the apoptotic pathway at the mitochondrial level. Consequently, 
the release of cytochrome c and Smac from the mitochondria is blocked. The upregulation of cIAP-
2 and the stabilization of the IAP–IAP complexes results in a direct block in the activation of 








In the present study an attempt was made to understand the mechanisms of apoptosis 
resistance in the Chlamydia infected cells. Some key host cell factors responsible for the 
apoptosis resistance were identified. Further cell biology approaches revealed the 
signalling pathways activated upstream of these factors. Overall a more accurate picture 
was obtained, of infection mediated regulation of the apoptotic machinery inside a cell.  
However, unsolved questions still remain in the bigger and more important picture of 
infection in the whole organism. What is the role of apoptosis resistance in the spread of 
Chlamydial infection in the host? Would the infection clear out faster if the cells in the 
system were sensitized to apoptosis, some way? 
Work on knock-out mice could be one of the strategies employed. In the case of Mcl-1, 
where the knock out is lethal to mice, a localized knock down attained in vivo with 
specially delivered siRNAs could be a solution. This strategy is ideal since the cells from 
an infected tissue (e.g. in the lungs or the urinary tract) can specifically be targeted with 
siRNAs mediated knock down, while the other parts of the body are not harmed.  
How effective is the resistance to apoptosis induced by cytoxic T lymphocytes (CTLs) in 
the spread of chlamydial infection in the body? It would be interesting to assess the 
infection in a Granzyme B/perforin knock-out mouse model, where the CTLs would be 
rendered ineffective of inducing apoptosis in the infected cells.  
Tumor cells, especially in solid tumors, have a hypoxic environment and often show HIF-
1 stabilization and subsequent HIF-1 transcriptional activity [176]. Further, a majority of 
human malignancies have an elevated expression of IAPs to promote tumor growth 
through the inhibition of cellular death [177]. Similarly, Mcl-1 has been shown to be up-
regulated in numerous hematological and solid tumor malignancies [178]. Very similar 
conditions exist in the chlamydial infected cell, and it is tempting to hypothesize that the 
increased levels of the crucial anti apoptotic proteins during chlamydial infection would 
create conditions in the cell that help in the tumor maintenance and foster its growth. In 
fact there is growing evidence of the association of chlamydial infections with certain 




cancer causing agents, e.g. the Human Papilolma Virus, HPV. The knowledge of the 
factors responsible for the apoptosis resistance in the infected cells identified in this study 
would be crucial for research on Chlamydia induced tumor development.  
Materials and Methods 
 
4 Materials and Methods 
4.1 Materials 
4.1.1 Cell lines 
 
Cell Lines Sources 
HeLa Human cervical epithelial cells 
HEp-2 Human larynx epidermal carcinoma 
cells 
Jurkat cells Human T cell Leukemia cell line 
END1 Human endocervix; cervix 
 
4.1.2 Cell culture media 





4.1.3 Chemical reagents 
Chemical  Supplier
Agarose, low melting point Sigma-Aldrich 
Brefeldin A Sigma-Aldrich 
CCCP Sigma-Aldrich 
CD95 antibody Immunotech 
Cisplatin Sigma-Aldrich 
Cycloheximide Sigma-Aldrich 
ECL plus NEN 
Hoechst33258 Sigma-Aldrich 
Mitotracker Orange Molecular Probes 
LY294002 Calbiochem 
PFA Roth 
Protein A Sepharose  Amersham 
Protein G Sepharose Amersham 
Staurosporin Sigma-Aldrich 
Thapsigargin Alexis Biochemics 
TNF-  B D Pharmingen 
U0126 Calbiochem 
Mitotracker red Molecular Probes 
Hoechst 33342 Sigma-Aldrich 
4.1.4 Primary antibodies 
Antigen  Dilution for IF Dilution for WB Company 
anti-chlamydial 
genus specific 
1:100 - Milan Analytica 
AG 
Rabbit polyclonal, anti-human PARP  1:5000 SantaCruz 
Mouse monoclonal, anti-human  Hsp60 1:100 1:2500 Stressgen Biotech 
Mouse monoclonal, anti-human -
tubulin 





Mouse monoclonal, anti-human 
Cytochrome c 
1:100 1:1000 Cell Signalling 
Mouse monoclonal, anti-human cIAP-
1  
- 1:250 BD Pharmingen 
Mouse monoclonal, anti-human cIAP-
2 
- 1:250 BD Pharmingen 
Rabbit polyclonal, anti-human Cleaved 
Caspase-3 
- 1:1000 Cell Signalling 
Mouse monoclonal, anti-human SMAC - 1:500 Cell Signalling 
Mouse monoclonal, anti-human XIAP - 1:250 BD Pharmingen 
Mouse monoclonal, anti-human MCL1 - 1:1000 BD Pharmingen 
Mouse monoclonal, anti-human HIF-
1  
1:100 1:1000 Alexa 
Mouse monoclonal, anti-human Lamin - 1:2000 SantaCruz 
Mouse monoclonal, anti-human 
Caspase-9 
- 1:1000 Upstate 
IF-immunofluorescence, WB- western blots 
4.1.5 Seconday antibodies 
ECLTM sheep anti-mouse peroxidase  1:3000 Amersham Bioscience 






4.2.1 Cell culture media for Chlamydia culture and maintenance 
Growth medium MEM, 1 % non essential amino acids, 2 mM L-Glutamine, 10 % 
FCS, 10 mM HEPES and 10 µg/ml gentamycin. 
Maintenance medium MEM, 1 % non essential amino acids, 2 mM L-Glutamine,  10 
mM HEPES, 10 µg/ml gentamycin and 1 µg/ml Cycloheximide. 
Infection medium MEM, 1 % non essential amino acids, 2 mM L-Glutamine,  10 
mM HEPES and 5 % FCS 
4.2.2 Indirect Immunofluorescence 
4 % PFA, pH 7.4 Dissolve 4 g of PFA in 50 ml H2O. Heat to 60°C while stirring and add 
1 ml 1 M NaOH. Add 10 ml 10 x PBS, cool down to RT and adjust pH 
to 7.4 (ca. 1 ml 1 M HCl) Make up the final volume to 100 ml and 
freeze in aliquots at -20°C 
10x TBS 200 mM Tris pH 7.5, 1.54 M NaCl, 20 mM EGTA, 20 mM MgCl2 
Moviol  13.3 % (w/v) Moviol 4-88, 33 % (w/v) Glycerin in 0.15 M Tris-HCl, 
pH 8.5 
4.2.3 Isolation of mitochondria 
Solution A  Solution B containing 2 mg/ml BSA 
Solution B  20 mM Hepes-KOH pH 7.6, 220 mM Mannitol, 70 mM sucrose, 1 mM 
EDTA, 0.5 mM PMSF 
Sucrose Buffer  10 mM Hepes-KOH pH 7.6, 0.5 mM sucrose 
 
4.2.4 SDS-PAGE and Western blot 
2x sample buffer  20 % Glycerin, 100 mM Tris-HCl pH 6.8, 4 % SDS, 200 mM DTT, 0.2 
% bromophenol blue 
Running buffer  0.25 M Tris, 1.918 M Glycin, 1 % SDS 





TBS-T  10 mM Tris-HCl pH 7.5, 100 mM NaCl, 0.1 % Tween-20 
Blocking solution  10 % milk powder in 3 % (w/v) BSA in TBS- 
Stripping buffer  62.5 mM Tris-HCl, pH 6.7, 10 mM β-Mercaptoethanol, 2 % (w/v) SDS, 
0.05 % Tween-20 
 
4.2.5 Protein staining / fixation 
Ponceau S  2 % PonceauS (w/v), 30 % TCA (w/v), 30 % sulfosalicylic acid (w/v) 
Coomassie solution  0.25 % (w/v) Coomassie Brilliant Blue R250, 50 % Methanol, 10 % 
glacial acetic acid 
Destainer  10 % ethanol, 10 % glacial acetic acid 
Fix-solution 25 % methanol, 10 % glacial acetic acid 
  
4.2.6 Immunoprecipitation 
Chaps buffer  150 mM NaCl, 10 mM HEPES pH 7.4, 1 % Chaps (w/v), protease 
inhibitors 
Lysis buffer 0.4 % Triton X-100, 20 mM Tris pH 7.2, 2 mM EDTA pH 7.2 
SPG buffer 75 g /l sucrose, 0.52 g/l KH2 PO4, 1.22 g/l Na2HPO4, 0.72 g/l glutamic 
acid, 10 % FCS 
RIPA buffer 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5 % NP-40, 0.5 % Triton 
X-100, 1 mM NaVO3, 10 mM Na-pyrophosphate, 1 mM NaF, 0.5 mM 
EDTA, 0.5 mM EGTA, 1 mM DTT, Protease inhibitor mix 
Protease inhibitor  1 g/ml of Aprotinin, 0.5 g/ml Leupeptin, 1 mM Pefabloc, 10 M 
Pepstatin 
MB buffer 400 mM Sucrose, 50 mM Tris, 1 mM EGTA, 5 mM 
mercaptoethanol, 10 mM KH2PO4, pH 7.6, 0.2 % BSA 








4.3.1 Growth and purification of Chlamydia 
Before harvest, bacteria were propagated in HeLa cells, grown in six well plates with 
Maintenance medium, MM, by incubating them at 37C for approximately two days. In 
case of C.pneumoniae infection the plates were centrifuged at 100 X g for 1 h to enhance 
the infection. After 55 to 70 hour post infection, MM was poured off and the cells were 
detached in cold HBSS (Biochrom) using 3 mm diameter glass beads or rubber police man. 
The cell suspensions were centrifuged at 500 x g and 4C for 10 min (Hermle 
Labortechnik, Wehingen, Germany) and the pelleted cells were then combined together 
and ruptured using glass beads and a Dounce homogeniser to ensure the breakage of cells. 
The lysates were centrifuged as before to sediment nuclei and cell debris. The supernatant 
was removed and recentrifuged at 20,000 x g for 40 min at 4C in a SS-34 rotor (Sorvall 
Instruments, CT, USA) to pellet chlamydiae. The crude bacterial preparations were 
suspended in 30% Percoll (Vol/ Vol) (Pharmacia, Uppsala, Sweden) in 10 mM HEPES, 
145 mM NaCl, pH 7.4 by repeated passages in 22 gauge needle and centrifuged again at 
90,720 × g (TFT65.13 Rotor, Kontron Instruments, Zürich, Switzerland) for 40 min at 4C. 
The harvested bacteria were washed once in sucrose phosphate glutamate buffer (SPG pH 
7.4), diluted and resuspended in the same buffer.  
Chlamydia suspensions were then aliquoted and frozen at -75C and freshly thawed before 
each experiment.  
 
Inclusion count 
The inclusion forming units per ml has been calculated as follows. The EB suspensions 
were diluted 5 or 10 fold and added onto the host cell monolayer and the plates were 
centrifuged at 100 X g for 1 h to enhance the infection. After adding approximately 1 ml of 
infection medium (IM) to these wells, plates were incubated for 48 h at 37C and 5% CO2. 
After incubation, the cells were permeabilised and stained with the chlamydial genus 
specific antibody (Table1). The stained inclusions were counted at 400 X magnifications 





total area of the monolayer was estimated as well (B). Fields in the monolayer C= B/A. 
The number of IFU/ ml can be calculated as follows: 
No of IFU counted 
 C  DF  V 
No of Fields examined 
DF- dilution factor of EB preparation 
V- factor determined by the volume of the inoculum 
 
4.3.2 Indirect immunofluorescence 
The cells were washed with PBS and fixed with 3% paraformaldehyde for 20 min at room 
temperature. The fixed cells were washed with PBS twice for 5 min either by placing the 
plates on the moving platform at a minimal speed or by rinsing them by tilting the plates. 
The following solutions were prepared: 
Solution A: 0.5 % of Triton X-100 in PBS,  
Solution B: 0.05 % of Triton X-100 with 0.2 % BSA in PBS and  
Solution C : 1 % Goat serum with 0.05 % of TritonX-100 in PBS.  
The cells were then permeabilised with Solution A for 5 to 10 min and washed with PBS 
twice followed by incubation with Solution B for 15 min at room temperature. It was then 
washed away by rinsing with PBS twice. The cells were further incubated with solution C 
for 20 min at room temperature. After washing with PBS once the primary antibody at the 
recommended dilution was prepared in solution C. About 25-30 μl of the primary antibody 
mix was then carefully added onto the cover slips and incubated at room temperature for 
one hour under moist conditions. After incubation, the cells were washed with PBS thrice 
and in the meantime the secondary antibody mix in solution C was prepared and added 
onto the cover slips after drawing all the PBS out. After incubating for 40 to 50 min the 
cells were washed and mounted onto glass slides with Moviol. In case of double staining 
the same procedure as mentioned before was repeated with another set of primary and 
secondary antibodies. For visualization of the mitochondria Mitotracker Red was added to 
living cells prior to fixation for 20 min at 37C. 
4.3.3 Smac release assay 
This method is based on the fact that Smac has a mitochondrial localization in untreated 





permeabilisation (MOMP), Smac localises to the cytosol resulting in the loss of the 
punctuate staining. This can be monitored microscopically. 
Control and Mcl-1 knockdown cells were grown on coverslips and infected with 
C. trachomatis. 24 hours post infection, apoptosis was induced in infected and control cells 
with TNFα and cycloheximide. After six hours, the cells were fixed with 4 % PFA/PBS. 
The cells were then washed once with PBS and permeabilised with 1 % Triton/PBS for 10 
minutes. Blocking was done using 1 % BSA and 0.05 % Tween 20 in PBS, for 30 minutes. 
The samples were incubated overnight with a mouse monoclonal anti-human Smac 
antibody (BD Pharmingen) at a dilution of 1:100 in PBS. The samples were washed twice 
with PBS and the bound antibodies were detected using an anti-mouse Cy-2 conjugated 
secondary antibody.  
The coverslips were examined with a Leica confocal microscope using the TCS software 
in accordance with established methods. Five fields were selected randomly for each 
sample and cells which have lost the punctuate staining were digitally recorded and the 
percentage of cells which have lost Smac staining in relation to those who who retained it 
were calculated. 
 
4.3.4 Induction of apoptosis 
To induce apoptosis, either 1 μM staurosporine (Sigma) or 40 ng/ml of TNF  
(Pharmingen, San Diego, California) together with 2 μg/ml of cycloheximide were applied 
to the cells for four to six hours. The control cells were incubated with cycloheximide 
alone.  
4.3.5 Transfection of siRNAs and subsequent infection  
To inhibit expression of genes by siRNAs, 50,000 cells/well were seeded in a 12-well plate 
at least 20 h prior to transfection. Short interfering RNAs designed for the inhibition of the 
genes under investigation and for luciferase (siLuc) as negative control were transfected 
using the Transmessenger transfection kit or the RNAiFect transfection kit (Qiagen). One 
day post transfection, the nearly confluent cells were infected with C. trachomatis and 24 h 
later the samples were analysed by immunoblot and apoptosis analysis. SiRNAs targeting 






 siMcl-1 [2] 5’-AAGAAACGCGGUAAUCGGACU-3’,  
siMcl-1 [3] 5’-AAGGACACACAAAGCCAATGG-3’,  
siBim 5’-CGGAGACGAGTTTAACGCTTA-3’,  
siBad 5’-ACGAGTTTGTGGACTCCTTTA-3’,  
siPuma 5’- CAGCCTGTAAGATACTGTATA-3’,  
siBid 5’-TAGGGACTATCTATCTTAATA-3’.  
For silencing of Mcl-1, both siRNAs were transfected together at a final concentration of 
60 nM each.  
 
4.3.6 Generation of cell lines expressing Mcl-1 shRNAs 
Stably shMcl-1 expressing HeLa cells were generated according to 
http://www.tronolab.com. 293T cells were transfected by calcium phosphate method with 
the target vectors pLVTH-M-shMcl and viral packaging vectors. After 48 h, lentiviral 
supernatants were filtered through a 0.45 m filter (concentrated by ultracentrifugation at 
25,000 rpm) and infections of HeLa cells were performed in the presence of polybrene 
(Sigma). 8 h post infection medium was exchanged and after 48 h GFP-positive cells were 
enriched by FACS sorting (FACSDiva, Becton Dickinson). Single clones of GFP-positive 
cells were lysed in sample buffer and the efficiency of gene silencing was checked by 
quantitative realtime PCR and immunoblot analysis as mentioned above. As control, HeLa 
cells were transduced with the empty vector and all cell lines were tested for interferon 
response to exclude non-specific effects. The sequence targeted by the mature shMcl RNA 
in the Mcl-1 mRNA was: 5’-UAGAGUGUAUACAGAACGAAU-3’. 
 
4.3.7 Apoptosis assays and quantification 
Detection of chromatin condensation 
Cells were seeded in 12 well plates on cover slips infected, and treated with apoptotic 
inducers as described above. After the specific time points the cells were washed twice 
with 1 X PBS and fixed at room temperature with 4 % PFA for 30 min. After twice 
washing with PBS, the cells were stained with Hoechst 33342 (1 mg/ml) for 15 min in 
dark. After two washes with PBS the cover slips were dried and mounted onto glass slides 





Different fields were then photographed through the connected digital camera. For 
quantification cells from five random fields for each sample were counted using a 40X 
objective lens. The number of apoptotic, nonapoptotic and the infected cells were counted 
and the percentage of apoptotic cells was calculated. 
 
Detection of caspase-3, cytochrome c and TUNEL assay 
Following the induction of apoptosis, the infected and uninfected cells were first subjected 
to the detection of C. trachomatis using specific antibodies. After being fixed in 4 % PFA, 
and washed with PBS, cells were incubated for 1 h with the rabbit polyclonal antibody 
specific for activated caspase-3, used at a final dilution of 1:100 (a gift from A. Srinivasan, 
Idun Pharmaceuticals, San Diego, California.). This was followed by incubation for 1 h 
with goat anti-rabbit immunoglobulin G coupled with DTAF (Dianova). The Terminal 
deoxynucleotidyl transferase-mediated dUTP-biotin Nick End Labeling (TUNEL) reaction 
was performed using the Apoptosis Detection System, Fluorescein, strictly in accordance 
with the manufacturer's instructions (Promega, Madison). Cytochrome c was detected with 
the mouse monoclonal antibody against holocytochrome c (Pharmingen). 
4.3.8 Preparation of cell lysates for immunoblotting 
Cells were trypsinised and washed twice with cold PBS at 4°C. Cell pellets containing 2 × 
105 cells were resuspended in 50 μl lysis buffer (62 mM Tris-HCl, 2 % SDS, 10 % 
Glycerol, 5 % β–mercaptoethanol pH 6.8) or in single detergent buffer (20 mM Tris- HCl 
pH 7.5, 150 mM NaCl, 1 % NP-40, 1 μg/ml Aprotinin, 0,5 μg/ml Leupeptin, 1 mM 
Pefabloc, 10 μM Pepstatin) and heated in a boiling water bath or a heating block for 10 
min. Cell lysates were removed by centrifugation (13000 rpm at 4° C) and the lysates were 
stored at – 20°C for further analysis. 
4.3.9 SDS-PAGE and immunoblotting 
Proteins were separated under reducing conditions for 1 h at 120 V. The gels were blotted 
overnight at 100 mA onto PVDF membranes (Millipore). Prior to this the PVDF 
membranes were activated by incubating them with methanol for a minute and then 
washed with TBST for 5-10 min. Membranes were blocked for 2 h in 3 % BSA in Tris-
buffered saline (TBS)/0.1 % Tween 20 (TBST) and then incubated for 1-2 h with suitable 





for another hour with the peroxidase coupled secondary antibody and the bound antibody 
was detected by enhanced chemiluminescence (NEN). The chemiluminescence was 
detected by exposing to a BioMac™ MR film (Eastman Kodak.Co.). The blots were 
sometimes stripped and probed with other antibodies. For stripping, the PVDF membranes 
were again activated by incubating them with methanol for a minute and then washed with 
TBST for 5-10 min. Then about 200 ml of stripping solution (62,5 mM of Tris-HCl pH 6,7 
with 10 mM Mercaptoethanol and 1 % SDS in distilled water) was added to these blots 
and incubated in a shaking waterbath at 50C for 30 min. The blots were washed well with 
TBST for 1-2 h by changing TBST for every 20 min. The stripped blots were then 
incubated with 3 % BSA in TBST and the same procedure was followed as mentioned 
above to reprobe them with a new antibody. 
4.3.10 Quantification of immunoblot data  
 
The blots were scanned using a Canon Scan 5000F scanner. Quantification was done by 
densitometry analysis using Adobe Photoshop CS3 (Adobe Systems Incorporated). An 
area around each band was selected and the mean intensity was calculated by the software. 
The mean intensity of a region on the blot near the bands was taken as a “blank”. The total 
intensity of any band was then calculated as the difference between the mean intensity of 
the band and the blank, multiplied by the pixel size of the area selected around the band.  
The total intensities of bands were normalized using the Actin control. The values were 
plotted on a relative scale with a value of 100 % assigned to the 0H value in each graph.  
Preparation of mitochondria free cytosolic fractions from cell extracts  
Hela cells were cultured in 150 cm2 flasks and harvested. The cells were pelleted by 
centrifugation for 5 min at 1200 RPM and 4 ºC. The pellet was washed with PBS and then 
resuspended in MB buffer (400mM Sucrose, 50mM Tris, 1mM EGTA, 5mM ß-
mercaptoethanol, 10mM KH2PO4, pH 7.6). The suspension was kept on ice for 20 minutes 
and the cells were then disrupted by pottering.   
The nuclei and cell debri were expelled by centrifugation at 3000 RPM for 2 minutes. The 






4.3.11 Gel filtration chromatography 
The mitochondria free cell cytosolic fraction isolated above, was applied to a Superdex 200 
HR 26/60 column (Amersham Pharmacia) at a flow rate of 1 ml/min. The column was 
equilibrated with PBS buffer.  Fractions, each 5 ml in volume, were collected starting at 80 
ml. The column void volume was 100 ml.  
The fractions were mixed with an equal volume of 25 % trichloroacetic acid and kept on 
ice for 30 minutes. These were then centrifuged at 4000 RPM for 30 minutes. The 
supernatant was carefully discarded and the pellet washed twice with acetone. The pellet 
was then dissolved in SDS sample buffer and analyzed by SDS-PAGE and 
immunoblotting.  
4.3.12 Softwares used 
Windows 2000, XP (Microsoft) 
MS Office (Microsoft) 
Mozilla Firefox 
Adobe Acrobat 7.0 (Adobe) 
Photoshop 6.0 (Adobe) 
Corel Draw 11 (Corel) 
ACT-1.2 (Nikon) 
Visicapture (Scion Corp.) 
Reference Manager 11 (Thompson ISI research soft), 
CellQuest Pro (BD) 
Image Reader LAS-3000 (Fujifilm Life Science) 
BasReader 3.14 (Fujifilm) 
Aida Image analyzer 4.03 (Fujifilm) 
Vector NTI 10 (Invitrogen) 
Chromas (Technelysium Pty) 
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